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Resumo 
 
 
O presente trabalho propõe-se a rever e compilar toda a bibliografia 
cientificamente relevante até à data, no que respeita as vias de sinalização 
antivirais implicadas na imunidade celular inata em células humanas.  
Com ênfase na proteína adaptadora MAVS, este trabalho explora as 
particularidades das vias de transdução de sinal e respetivos intervenientes em 
dois organelos celulares específicos: mitocôndrias e peroxissomas. Estas vias, 
em última instância, resultam na expressão de genes estimulados por 
interferões (ISGs), principais responsáveis pelo combate celular eficaz contra a 
replicação viral, montagem de partículas virais e libertação de viriões na célula 
infetada. 
Neste trabalho são ainda apresentadas propostas para investigações futuras, 
uma vez que ainda muito pouco se sabe sobre o papel dos peroxissomas nas 
respostas imunitárias inatas contra infeções virais. 
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Abstract 
 
The present paper presents a review and compilation of all the scientifically 
relevant bibliography to date, regarding the antiviral signalling pathways 
implicated in the cellular innate immune system in humans.  
Emphasizing the mitochondrial antiviral signalling adaptor (MAVS), this paper 
explores the special features of the signal transduction pathways and their 
components in two specific organelles: mitochondria and peroxisomes. These 
pathways, ultimately, result in the expression of interferon-stimulated genes 
(ISGs), which are primarily responsible for fighting against viral replication, viral 
particle assembly and virion release within the cell.  
In this paper, several proposals for further investigation are also presented, 
since there is still a lot to learn about the role of peroxisomes in the antiviral 
innate immune responses. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
“Science, my boy, is made up of mistakes, but they are mistakes which it is 
useful to make, because they lead little by little to the truth.” ― Jules Verne, 
Journey to the Center of the Earth  
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1 – Introduction 
 
1.1 – Mitochondria: general features and functions 
Mitochondria are among the largest cellular organelles in the eukaryotic cell, with 
the same approximate  size of an E. Coli bacterium (Lodish et al., 2008). They occupy 
a maximum of 25% of the cell cytosolic volume, depending on the cell type (e.g.: liver 
cells can have up to two thousand mitochondria, occupying a fifth of the cell volume 
(Alberts, 2008; Lodish et al., 2008). 
Despite being large enough to be visualized under light microscopy, the details of its 
structure were only recognized with the use of electron microscopy and their unique 
functions were first revealed upon the development of experimental procedures in 
order to isolate intact mitochondria (Alberts, 2008; Lodish et al., 2008). The first 
observations of intracellular structures that could represent mitochondria date back to 
the 1840s. In 1890, Richard Altmann recognized the ubiquitous occurrence of these 
structures and named them “bioblasts”. The term “mitochondrion” was coined by Carl 
Benda in 1898 and derives from the Greek “mitos” (thread) and “chondros” (granule), 
referring to the appearance of these structures during spermatogenesis (Ernster and 
Schatz, 1981).  
 
Figure 1 – Electron microscopy photograph of a mitochondrion. 
          (Hall, 2010) 
 
 
Mitochondria are usually portrayed as stiff elongated cylinders with an approximate 
diameter of 0.5 to 1μm. However, live cell studies have shown that mitochondria are 
incredibly dynamic and plastic organelles, constantly changing their shape, even fusing 
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with one another and splitting up again. As they move along the cytosol, they appear 
frequently associated with microtubules, which might determine the orientation and 
distribution of mitochondria in different cell types: in cardiac muscle cells they appear to 
be packaged around adjacent myofibrils while, in sperm cells, mitochondria are mainly 
found wrapped around the flagellum (Alberts, 2008). 
Each mitochondrion is surrounded by two specialized membranes that together 
create two separate mitochondrial compartments (Figure 2): an intermembrane space 
and a core space, named the mitochondrial matrix (Alberts, 2008). The outer 
membrane defines the external perimeter of mitochondria while the inner membrane 
has numerous convolutions and infoldings – named cristae – that greatly increase the 
surface area of this membrane (Lodish et al., 2008).  
 
Figure 2 – Scheme of a mitochondrion with the individualized internal compartments. 
Two membranes form the main structure of the mitochondrion, dividing it into three 
compartments: outer membrane, intermembrane space, inner membrane and matrix. The inner 
membrane possesses infloldings named cristae and contain ribosomes (blue spheres) facing 
the matrix. The matrix compartment contains, among others, the mitochondrial DNA (blue 
strands) and granules (yellow spheres). (Lodish et al., 2008) 
 
 
Each membrane has its own set of proteins. The outer membrane contains porins – 
transmembrane channels similar to bacterial porins – allowing the flow of ions, 
molecules and proteins no bigger that 5kDa, in and out of the intermembrane space. 
However, while the intermembrane space is chemically equivalent to the cytosol, the 
matrix is a much more selective space, due to the special features of the inner 
membrane (Alberts, 2008). Proteins account for ~76% of the total weight of the inner 
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membrane. Some of them are F0F1 complexes that synthesize ATP while others 
function in the transport of electrons, O2 and NADH. Others allow that some otherwise 
impermeable molecules such as ADP and Pi enter the matrix and molecules such as 
ATP exit the matrix. A great proportion of the inner membrane is composed of 
cardiolipin that helps to keep this membrane especially impermeable to ions, reducing 
the membrane permeability to protons (Lodish et al., 2008). 
The inner mitochondrial membrane, the cristae and the matrix are the sites where 
most of the reactions involving pyruvate and fatty acids oxidation into CO2 and H2O 
with ATP production take place – citric acid cycle and oxidative phosphorylation, 
respectively. This is a multistep process but it can be divided into three simple groups 
of reactions:  
1. Pyruvate and fatty acid oxidation into CO2 and combination with co-
enzyme A to form acetyl Co-A, coupled with NAD+ reduction into NADH and 
FAD into FADH2 – citric acid cycle. These electron transporters are not 
permanently bound to proteins and are the source of electrons to the electron 
transporter chain; most of these reactions occur in the matrix or in the inner 
membrane facing the matrix. 
2.  Transfer of electrons from NADH and FADH2 to O2, regenerating these 
electron transporters back to its oxidized form NAD+ and FAD – oxidative 
phosphorylation. These reactions take place at the inner membrane.  
3. Recovery of the stored energy in the electron transport chain in order to 
produce ATP at the inner membrane (Lodish et al., 2008). 
 
While most organelle proteins are coded in the nuclear genome of the cell, 
synthesized in ER ribosomes and then imported to the destination organelles, others, 
such as mitochondrial proteins, are coded by mitochondrial DNA and synthesized in 
ribosomes within the organelle itself (Alberts, 2008).  
The human mitochondrial genome contains 2 rRNA genes, 22 tRNA genes and 13 
protein-encoding sequences that are core constituents of the respiratory complexes 
embedded in the inner membrane. The mitochondrial DNA molecule is circular (like a 
typical bacterial genome) and, in mammals, it has around 16 500 base pairs, which 
accounts for less than 0,001% of the size of the nuclear genome. Mitochondrial 
genome is contained within the matrix and is usually arranged in clusters named 
nucleoids which are thought to be attached to the inner mitochondrial membrane. This 
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nucleoid organization resembles the one of bacteria and, as for bacteria, it does not 
possess histones (Alberts, 2008). 
 
The number of mitochondria and their shape varies among different cell types and it 
can change within the cell under special physiological conditions, so that mitochondria 
can be presented as spherical organelles or in a single branched structure (or 
reticulum). This arrangement is controlled by mitochondrial fission and fusion events 
that are regulated by a special set of GTPases localized at mitochondrial membranes 
(Alberts, 2008) – the members of the dynamin family: Mitofusins (Mfn1 and Mfn2) 
mediate the outer membrane fusion in mammals, while Opa1 mediates fusion of the 
inner  membrane; Drp1, which cycles between the cytosol and the outer membrane 
mediates mitochondrial fission (van der Bliek et al., 2013).  
 
 
 
 
Figure 3 – Representation of the mitochondrial growth and division events. 
a) Three proteins constitute the fusion/fission machinery of mitochondria: mitofusins (Mffn) 
mediate outer membrane fusion in mammals while Opa1 mediates inner membrane fusion; 
Drp1 (also known as DLP1) cycles between the cytosol and the mitochondrial outer membrane 
and mediates mitochondrial fission; b) Electron micrograph of a dividing mitochondrion in a liver 
cell. Adapted from: (Alberts, 2008; van der Bliek et al., 2013) 
 
 
 
Despite energy conversion from glucose or fatty acids into ATP being the most 
significant function of mitochondria – which are commonly designated as the 
“powerhouse of the cell” due to this feature – these organelles are involved in a much 
larger number of signaling pathways involving apoptosis, immune responses, calcium 
homeostasis, control of the cell growth and division, etc., rendering mitochondria as all-
purpose organelles (Lodish et al., 2008). 
 
a) b) 
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1.2 – Peroxisomes: general features and functions 
Peroxisomes differ from mitochondria in some aspects, such as the fact that they 
are surrounded by a single membrane and do not possess their own set of DNA 
(Alberts, 2008). However, they are a part of the basic equipment of the eukaryotic cell 
and perform important metabolic functions involved in the hydrogen peroxide and fatty 
acid metabolism, being therefore essential to the health and development of human 
beings (Islinger and Schrader, 2011; Schrader and Fahimi, 2008).  
Peroxisomes (originally called microbodies) were first described by a Swedish 
doctoral student J. Rhodin in 1954 but were only identified as organelles by the Belgian 
cytologist Christian de Duve in 1967. Peroxisomes were first defined as organelles 
where oxidation reactions take place leading to the production of hydrogen peroxide. 
Since hydrogen peroxide is harmful to the cell, these organelles contain an array of 
enzymes, particularly catalase, which decomposes hydrogen peroxide into O2 and 
water molecules. A variety of substrates are broken by these oxidation reactions in the 
peroxisomes, including fatty acids (β-oxidation), ethanol (particularly in liver cells) and 
uric acid (Cooper, 2000).  
 
Figure 4 – Fluorescence microscopy photograph of peroxisomes (green) and 
mitochondria (red) in human hepatoma cells.  
Peroxisomes vary in their morphology, cycling between a spherical, rod-shaped morphology 
and elongated tubular morphologies, while mitochondria are mainly found in the form of an 
interconnected tubular network. Peroxisomes can also present a “beads on a string” 
morphology during division events (arrow). Boxed region shows higher magnification view. N 
nucleus. Scale bars 10nm. Adapted from:  (Schrader and Fahimi, 2008) 
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However, peroxisomes functions are not restricted to oxidation reactions: they are 
multitask organelles, with functions that vary concerning the cell type or development 
state of the organism. Several specialized functions have been developed such as the 
penicillin biosynthesis in fungi, glycolysis in trypanosomes, photorespiration and 
glyoxylate cycle in plants and plasmalogen biosynthesis in mammals (plasmalogens 
are important constituents of myelin sheets in the brain) (Islinger and Schrader, 2011; 
Schrader and Fahimi, 2008). 
Besides catalase, peroxisomes possess other enzymes involved in the production 
and elimination of reactive oxygen species (ROS), such as superoxide dismutase, 
peroxiredoxins and glutathione peroxidase, actively participating in ROS metabolism, 
oxidative stress, neurodegeneration and carcinogenesis (Schrader and Fahimi, 2008). 
The fatty acid oxidation is a particularly relevant function, once it provides the main 
source of metabolic energy to the cell (Cooper, 2000). While in yeast and plants β-
oxidation of fatty acids depends exclusively on peroxisomes, in mammals this function 
takes place in both, peroxisomes and mitochondria. Both organelles have their own set 
of β-oxidation enzymes but have different specificities for certain fatty acids. Very long 
chain fatty acids and phytanic acid for example, can only be degraded in peroxisomes. 
Additionally, in mammals, peroxisomes are involved in the synthesis of bile acids, 
inflammation mediators and docosahexanoic acid (a modulator of neuronal function) 
(Islinger and Schrader, 2011). 
Peroxisomes can form by growth and division from pre-existing peroxisomes or by 
de novo formation from the ER. Peroxissomal division is preceded by membrane 
elongation through a mechanism that involves the peroxin Pex11p. The final requires a 
dynamin-related protein with GTPase activity and associated adaptor proteins such as 
DLP1 and Fis1 and Mff in mammals. Remarkably, these components are shared with 
mitochondria. On the other hand, the de novo formation of peroxisomes from the ER is 
less understood but it seems to require a maturation process that involves the 
recruitment of new membrane and matrix proteins. The peroxissomal matrix proteins 
are synthesized in free ribosomes at the cytosol and are imported into the 
peroxisomes. An interesting feature is that peroxisomes are able to import fully folded 
or even oligomeric proteins. This import is dependent upon two peroxissomal targeting 
signals: PST1 and PST2; these signals are recognized by receptor peroxins (Pex5p 
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and Pex7p, respectively) and interact at a receptor docking site at the peroxissomal 
membrane (Schrader and Fahimi, 2008). 
 
 
 
Figure 5 - Prototypical of peroxisome growth and division events.  
The peroxisomal growth and division process begins with the formation of a small protuberance 
from a mature peroxisome that keeps extending to a larger one where new internal components 
are being synthesized. This extension starts acquiring constriction points from where the newly 
formed peroxisomes will separate and become individualized. At the same time, new proteins 
are imported to the forming peroxisomes. The final division occurs through the actions of DPL1 
(which is responsible for the final division) and the membrane tail-anchored proteins Mff and 
Fis1 (the latter has been shown to interact with the elongation factor Pex11β), which recruit 
DLP1 to the constriction points. Mitochondria use a similar mechanism of growth and division. 
Adapted from: (Delille et al., 2009; Ribeiro et al., 2012) 
 
 
 
It has become recently evident that peroxisomes are dynamic and interconnected 
organelles that actively contribute to signaling events, developmental decisions, ageing 
and pathogen defence (Islinger and Schrader, 2011). It was recently discovered that 
peroxisomes are involved in antiviral innate immunity through the membrane MAVS 
protein (Dixit et al., 2010)– greatly developed in chapter 4. 
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1.3 – Viruses: structural and taxonomic features; overview of the replication 
cycle 
The Virus’ universe is rich in diversity and they are known for their ability to infect all 
kinds of organisms, from mycoplasmas, bacteria and algae to all kinds of plants and 
animals. Viruses vary in their structure, genome, organization, expression and 
replication and transmission strategies (Adelberg, 2007). 
The French bacteriologist Louis Pasteur was on the right path when we postulated 
that rabies was caused by a “living thing” smaller than bacteria and in 1884 was able to 
develop a vaccine against rabies. Pasteur also proposed the term virus (from the Latin 
“poison”) to name this special group of infectious agents. In the 1890s, D. Ivanovski 
and M. Beijerinck demonstrated that a tobacco disease was caused by a virus. Latter, 
Friedrich Loeffler and Paul Frosch discovered that an animal virus caused the foot-and-
mouth disease in cattle.  In the following decades, a bigger picture of the physical, 
chemical and biological nature of viruses began to shape up and around 1950s virology 
had grown as a multi-layered discipline (Talaro, 2002). 
1.3.1 - Viral Structure and Composition  
The organizational plan of viruses is very simple, as they only comprise the 
necessary parts to invade and control host cells: an outer coating and a core with one 
or more DNA or RNA strands (Talaro, 2002). 
 All viruses have a protein capsid that surrounds the nucleic acid and central core. 
Together, capsid and nucleic acid are called as nucleocapsid. Some members of viral 
families have an additional coating named envelope that is nothing more than a 
modified part of membranes of the host. Viruses that only possess a nucleocapsid are 
called naked viruses and have different mechanisms than enveloped viruses of 
entering and exiting host cells. The virus particle is commonly designated as virion 
(Talaro, 2002). 
The capsid is composed of identical subunits called capsomers. These capsomers 
self-assemble into the final capsid structure, and, depending on their shape, they can 
be arranged in two different forms: helical and icosahedral (Talaro, 2002). 
Helical capsids are simple with rod-shaped capsomers that bind a series of hollow 
discs to form a structure that resembles a bracelet. These discs bind each other to form 
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a continuous helix in which the nucleic acids are coiled. The icosahedral capsids form 
a three dimensional structure (20 sides of equilateral triangles with 12 corners), with 
capsomers arranged in different ways: some build their capsid from a single type of 
capsid while others contain different types. Individual capsomers can have a ring or 
dome like shape, and the packaging of the nucleic acid occurs in the centre of the 
icosahedron, forming the nucleocapsid (Talaro, 2002). In spite of their icosahedral 
shape, most capsids have a spherical or cubical appearance (Adelberg, 2007).  
Viruses only have one kind of nucleic acid, RNA or DNA – never both at the same 
time – that encodes the genetic information necessary for viral replication. Their 
genome can be single or double stranded, linear or circular, segmented or non-
segmented, and the type of nucleic acid, their strandedness and size are the main 
features used to classify viruses into families (Adelberg, 2007). 
A given number of virus families have an envelope in addition to the capsid in their 
structure. This lipid layer is acquired when the nucleocapsid buds through host 
membranes (organelle membranes or the cell membrane itself) during its maturation 
process. The phospholipidic content of the viral envelope is determined by the cell 
membrane type that is involved in the budding process. There are also glycosylated 
viral proteins protruding from the envelope that are exposed at the surface of the viral 
particle – designated peplomers. These glycoproteins are usually the ones involved in 
the attachment of the viral particle to specific host receptors – representing important 
viral antigens – and are also involved in the fusion of the envelope with the host cell 
membrane (Adelberg, 2007). 
The main purpose of viral proteins is to facilitate the transfer of the nucleic acid from 
a host cell to another. In order to do so, they protect the viral genome against nuclease 
inactivation and provide structural symmetry to the viral particle. Some viruses possess 
enzymes such as RNA polymerase and reverse transcriptase, inside their virions that 
are essential to the beginning of the replication cycle when the virion enters the host 
(Adelberg, 2007). 
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1.3.2 - Classification and Taxonomy 
The following features are used to classify and organize viruses into families: 
1- Virion morphology, including size, shape, type of symmetry, presence or 
absence of peplomers and/or membranes 
2- Viral genome properties such as the type of nucleic acid, genome size, 
strandedness (single stranded, double stranded), linearity or circularity, sense 
(positive, negative or ambisense), segments (presence, number and size), 
nucleotide sequence, G+C content, and the presence of special features 
(repetitive elements, isomeration, 5’ terminal cap, 5’ terminal linked protein, 
etc.) 
3- Physical and chemical properties of the virion, including molecular 
weight, buoyant density, pH and heat stability, susceptibility to chemical and 
physical agents such as ether and detergents. 
4- Viral proteins properties such as size, number, functional activities, 
amino acid sequence, modifications, etc.  
5- Genome organization and mode of replication: genetic order, number 
and position of open reading frames, replication strategies and patterns of 
transcription and translation, cellular sites, etc.  
6- Antigenic properties 
7- Biological properties such as the host range, modes of transmission, 
vector relationships, pathogenicity, tissue tropism and pathology (Adelberg, 
2007). 
 Taking into account these special features, it was established a taxonomy system 
where viruses are separated in large groups designated as families; the names of the 
families have the suffix –viridae. Within each family, there can be subfamilies (suffix –
virinae) that comprise subgroups called genera that are classified based in 
physicochemical or serologic differences. Genus names have the suffix – virus and 
Orders (suffix – virales) can be used to group virus families (Adelberg, 2007). 
The latest virus taxonomy release (July 2013) by the International Committee on 
Taxonomy of Viruses (ICTV) had organized viruses into 8 Orders: Caudovirales, 
Herpesvirales, Ligamenvirales, Mononegavirales, Nidovirales, Picornavirales and 
Tymovirales and another one for virus families without an assigned order and together 
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they comprise  around 103 families, with ~40 subfamilies and countless genera and 
genus (International Committee on Taxonomy of Viruses, 2013).  
Another virus classification system was proposed in 1971 by David Baltimore, which 
divides viruses into seven groups according to their genome type (RNA, DNA, single-
stranded (ss), double-stranded (ds), positive or negative sense) and their method of 
replication (see Figure 6) (Baltimore, 1971; ViralZone, 2014). 
 
 
Figure 6 – The Baltimore Classification of viruses.  
David Baltimore developed a virus classification system that groups viruses into families, 
depending on their type of genome. Group I encompasses double-stranded DNA viruses, which 
usually replicate within the nucleus of the host cell, requiring host polymerase in order to 
replicate their viral genomes. Group II covers all single-stranded DNA viruses, which also 
replicate within the nucleus. Group III includes double-stranded RNA viruses, that possess 
segmented genomes where each of the genes codes for a single protein. Group IV and V 
consist of single-stranded RNA viruses, with positive (group IV) or negative (group V) sense, 
which replicate in the cytoplasm (within their own capsids), not depending on host polymerases 
as much as DNA viruses do. Group VI comprises positive-sense, ssRNA viruses which require 
a DNA intermediate, using reverse transcriptases to convert the +ssRNA into DNA(Baltimore, 
1971). Lastly, group VII covers dsDNA viruses, who are not considered DNA viruses (like in 
Group I viruses), but rather reverse transcribing viruses, as they replicate through a RNA 
intermediate (Temin, 1985).  
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Table 1 – Virus’ classification according to family, virion size, type of symmetry, presence or absence of envelope, genome features and size, replication strategy and 
known viruses of each family or associated pathologies.  
Adapted from: (Adelberg, 2007) and (ExPASy, 2014); images courtesy of (ExPASy, 2014; The Science Picture Company, 2014; Zygote Media Group Inc., 2014); (+) –  positive sense strand;  (-) –  
negative sense strand; ss – single stranded; ds – double stranded; kb – kilobases; kbp – kilobase pairs; nm – nanometers 
 
Virus Family  
Virion Size 
(diameter) 
Type of 
Symetry 
Envelope 
Genome 
Features 
Genome 
Size 
Replication 
Strategy 
Viruses/Pathologies  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DNA 
Viruses 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parvoviridae 18-26 nm 
icosahedral        
(32 
capsomers) 
no 
linear; 
ssDNA 
5.6 kb 
nuclear replication in 
hosts undergoing 
active cell division 
Parvovirus B19 - causes a 
childhood exanthem 
called "fifth disease" 
 
Parvovirus B19 
Polyomaviridae 45 nm 
icosahedral         
(72 
capsomers) 
no 
circular; 
dsDNA 
5 kbp nuclear replication 
JC virus 
(leucoencephalopathy), 
BK virus (mild respiratory 
infection), KI virus, WU 
virus  
Murine Polyomavirus 
Papillomaviridae 55 nm 
icosahedral        
(72 
capsomers) 
no 
circular; 
dsDNA 
8 kbp nuclear replication 
Human papillomaviruses - 
genital cancers 
 
Human Papillomavirus 16 
Adenoviridae 70-90 nm 
icosahedral     
(252 
capsomers) 
no 
linear; 
dsDNA 
26-45 kbp nuclear replication 
51 types; Adenovirus 
serotype 14 (severe 
respiratory infection)  
 
Human Adenovirus 
Herpesviridae 150-200 nm 
icosahedral     
(162 
capsomers) 
yes 
linear; 
dsDNA 
125-240 
kbp 
nuclear replication 
herpes simplex type 1 
(oral) and type 2 (genital), 
varicella-zoster, 
cytomegalovirus, Epstein-
Barr  
Herpes simplex 
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DNA 
Viruses 
 
 
Anelloviridae 30-32 nm icosahedral no 
circular; 
ssDNA 
3,8 kb nuclear replication 
Alphatorquevirus; 
Betatorquevirus; 
Gamatorquevirus; 
Asymptomatic; may be 
associated with hepatitis, 
pulmunary diseases, 
myopathy and lupus 
 
Anelloviriade structure 
Hepadnaviridae 40-48 nm icosahedral yes 
circular; 
dsDNA 
3,2 kb 
nuclear and cytosolic 
replication 
Hepatitis B virus; chronic 
hepatitis; can develop to 
liver cancer 
 
Hepatitis B virus 
Poxviridae 
220-450X140-
260 nm 
brick-like or 
ovoid 
structure 
yes 
linear; 
dsDNA 
130-375kbp 
exclusively cytosolic 
replication 
Smallpox; Vaccinia; 
Molluscum contagiosum 
 
Smallpox virus 
 
 
 
 
 
 
 
 
 
RNA 
viruses 
 
 
 
 
 
 
 
 
 
 
Picornaviridae 28-30 nm icosahedral  no  +ssRNA 7.2-7.8 kb cytosolic replication 
Enteroviruses; 
Rhinoviruses; 
hepatoviruses (hepatitis 
A) 
 
Human Rhinovirus 
Astroviridae 28-30 nm icosahedral no 
linear; 
+ssRNA 
6.4-7.4 kb cytosolic replication gastroenteritis 
 
Astrovirus 
Caliciviridae 27-40 nm icosahedral no  +ssRNA 7.4-8.3 kb cytosolic replication 
Norwalk virus (acute 
gastroenteritis) 
 
Norwalk virus 
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RNA 
viruses 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reoviridae 60-80 nm icosahedral  no 
linear; 
segmented; 
dsRNA 
16-27 kbp cytosolic replication 
Rotaviruses that cause 
gastroentheritis 
 
Rotavirus 
Togaviridae 65-70 nm icosahedral yes 
linear; 
+ssRNA 
9.7-11.8 kb cytosolic replication Rubella virus 
 
Rubella virus 
Flaviviridae 40-60 nm 
spherical or 
pleomorphic 
yes  +ssRNA 9.5-12.5 kb cytosolic replication 
Dengue and Yellow Fever 
viruses 
 
Dengue virus 
Arenaviridae 120 nm pleomorphic yes 
circular; 
segmented; -
ssRNA or 
ambisense 
10-14 kb cytosolic replication 
Hemorrhagic fever 
syndromes; Guanarito 
virus, Junin virus, Lassa 
virus, Lujo virus, 
Machupo virus, Sabia 
virus  
Lassa virus 
Coronaviridae 120-160 nm 
spikes 
arranged in a 
fringe at the 
surface (like a 
solar corona) 
yes  +ssRNA 27-32 kb cytosolic replication 
SARS (severe acute 
respiratory syndrome) 
 
Coronavirus 
Retroviridae 80-110 nm icosahedral  yes 
2 copies of 
+ssRNA; 
linear 
7-11 kb 
each copie 
nuclear replication; 
reverse transcriptase 
leukemia and sarcoma 
viruses; HIV 
 
Human Immunodeficiency 
virus (HIV) 
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RNA 
Viruses 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Orthomyxoviridae 80-120 nm helical yes 
linear; 
segmented -
ssRNA 
10-13.6 kb 
nuclear replication; 
hematoglutinin and 
neuraminidase activity 
Influenza viruses 
 
Swine Influenza virus (H1N1) 
Bunyaviridae 89-120 nm 
spherical or 
pleomorphic 
yes 
triple-
circular 
segment; -
ssRNA or 
ambisense 
11-19 kb cytosolic replication 
Hemorrhagic fevers and 
neuropathies; severe 
pulmonary syndrome 
 
Orthobunyavirus structure  
Bornaviridae 80-125 nm spherical yes 
linear; -
ssRNA 
8.5-10.5 kb nuclear replication  Borna disease (horses) 
 
Borna virus 
Rhabdoviridae ~78x180 nm bullet-shaped yes 
linear; -
ssRNA 
13-16 kb 
cytosolic and nuclear 
(plants) replication 
Rabies virus, Vesicular 
stomatitis virus 
 
Rabies virus 
Paramyxoviridae 150-300 nm pleomorphic yes 
linear; -
ssRNA 
16-20 kb 
hematoglutinin 
activity 
mumps, measles, 
respiratory syncytial 
viruses 
 
Mumps virus 
Filoviridae ~89X1000 nm pleomorphic yes 
linear; -
ssRNA 
19 kb cytosolic replication Marbog and Ebola viruses 
 
Ebola virus 
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RNA 
viruses Arboviridae 
ecological group; not a viral family; diverse chemical and physical properties; complex replication cycle --> use arthropods as vectors of infection to vertebrate 
hosts through mosquito/tick bite 
Other 
Viruses 
Viroids  
not adequate with typical definition of viruses; nucleic acids without protein coating; in plants are ssRNA; viroid RNA doesn't encode protein products; 
replication mechanism completely oblivious 
Prions 
absense of nucleic acid, only proteins - might not be a virus at all; hihgly resistant to heat, formaldahyde and UV light 
inactivation; enconded by a celular gene;cause prion disease - transmissible spongiform encephalopathies 
 
Prion (Mad Cow disease) 
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1.3.3 - Viral Replication Cycle 
Viruses can only multiply in living cells and the host must provide the energy and 
synthesis machinery and precursors for the synthesis of viral proteins and nucleic acids 
(Adelberg, 2007). Although this cycle is a continuous process, it helps to define the 
replication cycle into sequential events. The general phases of the animal viruses’ 
cycle are as follows: Adsorption/Attachment  Penetration and Uncoating  
Replication (viral genome expression and viral components synthesis)  
Assembly/Morphogenesis Release (Figure 7). The length of an entire replication 
cycle varies from 8 hours in polioviruses to 36 hours in herpesviruses (Adelberg, 2007; 
Talaro, 2002). 
 
 
Figure 7 – General representation of a replicative cycle in animal viruses  
Two types of viruses are compared: an enveloped and a naked virus. (Talaro, 2002) 
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1.3.3.1 - Adsorption, Penetration and Uncoating  
The first step in viral infection is the attachment of a virion with a specific receptor 
at the surface of the host cell membrane. These receptors are usually glycoproteins, 
however, in certain cases viruses can bind to protein sequences or to oligosaccharides. 
The presence or absence of the receptors is a determinant for cell tropism and viral 
pathogenicity, since not all cells in a host organism express the necessary receptors. 
For example, HIV virus binds to CD4 receptor in immune cells while Epstein-Barr virus 
recognizes the CD21 receptors in B cells (Adelberg, 2007). 
Upon binding to the cell surface, the virion is internalized – penetration. Some 
viruses use receptor-mediated endocytosis with uptake of the viral particles inside 
endosomes, while others (usually the enveloped viruses) penetrate directly their viral 
particles through the cell membrane with the interaction of a viral fusion protein with a 
secondary receptor (Adelberg, 2007).  
The uncoating can occur simultaneously or right after penetration and it consists in 
the physical separation of the nucleic acid from the external virion structure. The viral 
genome can be released in the form of free nucleic acids or nucleocapsids that usually 
have polymerases (Adelberg, 2007). 
 
 
Figure 8 – Means of penetration of the host cell membrane by animal viruses. 
(a) endocytosis and uncoating of a non-enveloped virus; (b) Fusion of the cell membrane with 
the viral envelope (mumps virus). (Talaro, 2002) 
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1.3.3.2 - Replication  
Viral nucleic acids must be transcribed into mRNAs in order to the expression and 
duplication of the genetic information to be successful. Once this is achieved, viruses 
hijack cell components to translate these newly formed mRNAs. Different groups of 
viruses use different pathways to synthesize mRNAs depending on the structure of the 
nucleic acid (RNA or DNA), and some of them require RNA polymerases in order to 
synthesize their mRNAs (Adelberg, 2007).  
During the course of viral replication, all virus-specific molecules are synthesized in 
a well-coordinated fashion; some are produced in an early stage of the infection while 
others only begin their synthesis later on. There’s also a quantity control, since not all 
molecules are produced in the same quantity (Adelberg, 2007).  
The intracellular sites where the different replication events take place also varies 
from group to group (Table 1) but, in general terms, viral proteins are synthesized in 
polyribosomes with virus-specific mRNAs in the cytosol; viral DNA is usually replicated 
within the nucleus while viral RNA is duplicated in the cytosol, with a few exceptions 
(Adelberg, 2007). 
1.3.3.3 - Assembly and Release  
The newly synthesized viral genomes, proteins and capsids all come together to 
form the progeny viruses. General rule, non-enveloped viruses accumulate inside the 
infected cells until they end up lysing and releasing the viral particles. Enveloped 
viruses mature through a budding mechanism. Specific envelope glycoproteins are 
inserted at the cell membrane so that nucleocapsids can bud through the membrane at 
these sites, and doing it, they acquire their envelope. Budding usually occurs at the cell 
membrane but it can happen in other cell membranes (i.e., Golgi apparatus, 
endoplasmic reticulum) (Adelberg, 2007).  
 
Figure 9 – Maturation of an enveloped virus with acquisition of envelope and spikes 
(parainfluenza virus).  
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 (Talaro, 2002) 
 
 
 
1.4 – Host defence mechanisms: Innate Immune response and Pattern 
Recognition Receptors 
The defence systems have evolved to protect cells against the invasion of 
pathogenic microorganisms, being a system that is able to create a variety of cells and 
molecules that act together in a dynamic network in order to specifically recognize and 
eliminate a never ending variety of invaders.  Functionally, the immune response can 
be divided into two phases: recognition and response. The recognition is extremely 
specific and it is able to distinguish subtle chemical differences that differentiate one 
pathogen from another. Besides, it is able to tell apart foreigner molecules from the 
ones of the own organism. Once the pathogen is recognized, the immune system 
recruits an array of cells and molecules in order to induce an effector response so that 
the invader organism can be neutralized and eliminated. Thus, the immune system is 
capable of converting the initial recognition event and processing it into effector 
responses, each response being highly specific to clear a particular type of pathogen. 
A later exposure to the same pathogen may induce a memory response, 
characterized by a faster and stronger immune reaction that acts in order to clear the 
pathogen and prevent the development of a disease state (Kindt et al., 2007).  
The immune system is typically divided in two main components: the innate 
immune response that provides the first line of defence against infections (i.e.: 
barriers like the skin, mucous membranes, phagocytic cells, macrophages and 
neutrophils) and it is unspecific for any given pathogen; and the adaptive immune 
response that is highly specific, only takes place after the presentation of an antigenic 
challenge and possesses a “memory” property (the main agents are lymphocytes and 
antibodies). Since this second type of response takes some time to develop 
(approximately five to six days after the initial exposure to the pathogen), the innate 
response provides the first line of defence against the critical period, right after the 
exposure to the pathogen (Kindt et al., 2007). 
The innate immune response comprises four types of defence barriers: anatomical, 
physiological, phagocytic and inflammatory (Kindt et al., 2007).  
The physical and anatomic barriers, such as the skin and mucous 
surfaces/membranes, are the actual first line of defence against infections, since they 
are effective barriers against the entry of most microorganisms. For example, the skin 
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has sebaceous glands that produce oily secretions named sebum, which maintains the 
skin pH between 3 and 5, inhibiting the growth of most microorganisms. However, 
breaks in the structure of the skin such as scratches, wounds or abrasions or even the 
bite of insects might introduce pathogens into the lower layers of the skin and present a 
potential route of infection. On the other hand, the conjunctivae and food, respiratory 
and urogenital tracts are lined by mucous membranes with an external epithelial layer 
and a connective tissue layer underneath. Saliva, tears and mucous secretions have 
antibacterial or antiviral substances that act in order to wash away potential invaders. 
Mucous traps foreigner microorganisms and in the lower respiratory tract, the mucous 
membrane is covered by cilia (hair-like protrusions from the cell membrane of epithelial 
cells); the synchronized movement of cilia propels the pathogens trapped in the 
mucous outside of this tract (Kindt et al., 2007). 
The physiological barriers include temperature, pH and soluble molecules 
associated with cells. The gastric acidity is an example of this type of barrier, since very 
few microorganisms can survive in such environment. Soluble factors such as 
lysozyme, interferons and complement proteins also contribute to this kind of innate 
barrier. Lysozyme is an hydrolytic enzyme found in mucous secretions and in tears and 
it is able to cleave the peptidoglycan layer of the bacterial wall. Interferons constitute a 
group of proteins produced by virus-infected cells that function to bind to adjacent cells 
and induce a generalized antiviral state. Several specific and unspecific mechanisms 
are able to activate complement proteins, render them able to damage the pathogen 
membranes either destroying them or facilitating their clearance. Collectins were also 
found to kill certain types of bacteria by direct breakdown of their lipid membranes or by 
aggregating bacteria to augment the susceptibility to phagocytosis (Kindt et al., 2007). 
Another important defence mechanism is the ingestion of pathogens or extracellular 
materials through phagocytosis. Most of phagocytic events are taken by specialized 
cells such as blood monocytes, neutrophils or tissue macrophages (Kindt et al., 2007). 
Tissue damage caused by wounds or pathogenic invaders induces a complex 
sequence of events known as inflammatory response. Certain microbial components 
can trigger an inflammatory response through interactions with cell surface receptors 
and the final result can be the recruitment of a specific immune response or the 
clearance of the invader by the components of innate immune response. The cardinal 
signs of inflammation – redness, swelling, heat, pain and sometimes loss of function – 
reflect the three main events of the inflammatory response (Kindt et al., 2007). 
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Vasodilatation of the surrounding capillaries takes place as the blood vessels that 
transport blood constrict, resulting in the ingurgitation of the capillary network 
(responsible for the redness and increase in tissue temperature). An increase of 
capillary permeability facilitates the influx of exudate and cells from the capillaries into 
the tissue and the accumulation of exudate contributes to the tissue swelling (edema). 
The migration of phagocytic cells to the capillaries walls (margination) is followed by 
the intake from the capillaries into the tissue (diapedesis) and finally the migration 
through the tissue to the site of infection (chemotaxis). As the phagocytes accumulate 
and begin their phagocytic activities, lytic enzymes are released and can damage the 
surrounding cells. The accumulation of dead cells, digested material and fluids forms 
the known pus (Kindt et al., 2007). 
 
Figure 10 – The Inflammatory response. 
 The entry of a foreign body into the tissue causes tissue damage accompanied by the release 
of vasoactive and chemotactic factors. These factors induce increased blood flow to the 
affected area, increased capillary permeability and influx of white blood cells such as 
phagocytes and lymphocytes from the blood into the tissue. (Kindt et al., 2007) 
 
 
Once the inflammatory response decreases and most of the debris are cleared by 
phagocytic cells, tissue repair and regeneration begin. Capillaries grow into fibrin of a 
blood clot and new cells of connective tissue (fibroblasts) replace fibrin and the clot 
dissolves. As the fibroblasts and capillaries accumulate, scar tissue is formed (Kindt et 
al., 2007). 
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1.4.1 – Pattern Recognition Receptors 
In order to properly initiate an immune response against an infectious agent, the 
innate immune cells must have “something” that allows them to recognize certain 
microbial components patterns (commonly known as Pathogen-associated molecular 
patterns – PAMPs) which are inherent to the majority of invader pathogens. Otherwise 
they can recognize danger signals exposed at the surface of or released from 
damaged cells (Danger-associated molecular patterns – DAMPs). In fact there are 
cytosolic molecules and cell surface receptors with the ability of recognizing pathogen 
patterns, the so called, pattern-recognition receptors (PRRs). These recognized 
patterns include combinations of sugars, certain proteins, particular molecules with lipid 
content and some nucleic acid motifs. The ability of PRRs to distinguish self and 
nonself components is remarkable, since the targeted molecular pattern is only 
produced by the pathogen and never by the host (Kindt et al., 2007). 
There are multiple families of PRRs, the best characterized including those 
associated with the cell membrane such as the Toll-like receptors (TLRs) and C-type 
lectin receptors (CLRs) and cytosolic receptors such as the NOD-like and RIG-I-like 
receptors (NLRs and RLRs, respectively). In general terms, the recognition of ligands 
by PRRs triggers signal transduction pathways which results in the expression of pro-
inflammatory cytokines, chemokines and antiviral molecules (interferons); with the 
exception of NLRs that lead to the formation of multiprotein complexes named 
inflammasomes that serve as cleavage and activation platforms for caspase-1. 
Caspase-1 promotes maturation and secretion of IL-1β (interleukine-1β) and IL-18, 
which amplifies even further the pro-inflammatory response [reviewed at (Koyama et 
al., 2008; Wilkins and Gale, 2010)]. 
1.4.1.1 – Toll-like receptors 
Toll-like receptors are a transmembrane family of PRRs that are expressed in a 
variety of immune and non-immune cells, including monocytes, macrophages, dendritic 
cells, neutrophils, B and T cells, fibroblasts, endothelial and epithelial cells. TLRs 
initiate the immune response after the recognition of PAMPs presented in microbial 
molecules or endogenous DAMPs released by damaged cells. There are ten functional 
TLRs in humans: TLR 1, 2, 4, 5, 6 and 10 are expressed at the cell surface and mainly 
recognize membrane or wall components of pathogens, while TLR 3, 7, 8 and 9 are 
expressed at membranes of endolysosomal compartments and recognize nucleic 
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acids. TLRs have a variable number of ligand-sensing, leucine-rich repeats at their N-
terminal and a cytosolic domain Toll-interleukin-1 receptor (TIR). TIR domain mediates 
interactions between TLRs and adaptor proteins involved in the regulation of the 
downstream signaling such as MyD88 (Myeloid differentiation primary response gene 
88), TRIF (TIR-domain-containing adapter-inducing interferon-β), TRAM (Toll-receptor-
associated molecule) and TIRAP (toll-interleukin 1 receptor (TIR) domain-containing 
adaptor protein; also named MAL [MyD88 adapter-like]). The signaling pathways 
downstream promote the expression of pro-inflammatory cytokines, chemokines and 
type I and III interferons (Kawai and Akira, 2011).  
 
1.4.1.2 – C-type lectin receptors 
C-type lectin receptors (CLRs) are a diverse family of soluble and transmembrane 
proteins that have one or more C-type lectin-like domains (CTLDs) and are particularly 
important in antifungal immunity. Most CLRs that function as PRRs belong to the 
Dectin-1 or the Dectin-2 subgroups. Members of these groups are transmembrane 
proteins expressed mainly in monocytes, macrophages and dendritic cells that 
recognize fucose, mannose or glycan carbohydrate structures. Dectin-1 and dectin-2 
are the best characterized CLRs that function as PRRs and both have been showing to 
promote NF-kB canonical signaling through the activation of SYK (spleen tyrosine 
kinase) and a multiprotein complex of CARD9, Bcl-10 and MALT1; they also activate 
NFAT and AP-1, and dectin-1 also regulates NF-kB activity through the non-canonical 
NF-kB pathway and through Raf-1-mediated phosphorylation and acetylation. As a 
result, the signaling pathways initiated by either of these two CLRs can control the 
expression of numerous cytokines that direct the innate and adaptive immune 
response. Signaling pathways activated by CLRs can also directly regulate or modulate 
TLR signaling; upon activation, DCIR (Dendritic Cell Immunoreceptor) and MICL 
(Myeloid C-type lectin-like receptor) recruit the phosphatases SH2-domain-containing 
protein tyrosine phosphatase 1 (SHP-1) and SHP-2 and inhibit TLR8 and TLR9 
(Hoving et al., 2014).  
 
1.4.1.3 – NOD-like receptors 
The Nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) 
are cytosolic receptors that provide a second line of defence against invader 
pathogens. The NLR family comprises 22 proteins that are divided in subfamilies 
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(NLRA, NLRB, NLRC, NLRP e NLRX) based on their protein interacting N-terminal 
domains; additionally, all NLRs have a nucleotide-binding/oligomerization domain and 
a variable number of ligand-sensing, leucine-rich repeats at their C-terminals.  NOD1 
and NOD2 are the best characterized NLRs that belong to the NLRC family, 
recognizing bacterial peptidoglycan components. Upon activation, NOD1 and NOD2 
homodimerize and recruit signaling molecules leading to the pro-inflammatory cytokine-
dependent NF-kB/AP-1 expression and type I interferon expression, dependent of IRF-
3/IRF-7. Other NLRs are activated by a different array of pathogens or endogenous 
danger signals and oligomerize in order to form multiprotein complexes 
inflammasomes. The oligomerization into inflammasomes induces the cleavage and 
activation of caspase-1 that promotes the processing and secretion of IL-1β and IL-18 
and can induce cell-death known as pyroptosis (Kanneganti, 2010). 
 
1.4.1.4 – RIG-I-like receptors 
The RIG-I-like receptors (RLRs) are a family of cytosolic sensors for viral RNAs 
that include the retinoic acid-inducible gene-I (RIG-I), the melanoma differentiation-
associated 5 (MDA5) and the laboratory of genetics and physiology 2 (LGP2). These 
RLRs are composed of a DexD/H box RNA helicase domain, a C-terminal repressor 
domain and two caspase recruitment domains at their N-terminal. The LGP2 doesn’t 
have the CARD domain as the other two RLRs, consisting of a RNA helicase domain 
and a repressor terminal. RIG-I and MDA5 function as cytoplasmic sensors of RNA to 
induce the IFN-I production in non-immune cells (Loo and Gale, 2011). 
The two best characterized RIG-I-Like Receptors (RLRs), RIG-I and MDA5, are 
ubiquitously expressed in the cytosol of several cell types, and are able to recognize 
structurally distinctive RNA species that reach the cytosol of the host cell, by infection 
or by means of transfection (Dixit and Kagan, 2013). 
The Retinoic acid-inducible gene-I (RIG-I) was first identified as an induced gene in 
promyelocytic leukaemia cells after treatment with retinoic acid (Sun, 1997), while the 
melanoma differentiation associated gene 5 (MDA5) was first identified in a 
differentiation-induction subtraction hybridization screen, designed to define genes 
regulated upon induction of differentiation, in human HO-1 melanoma cells (Jiang and 
Fisher, 1993).  
Evidences suggest that RIG-I resides in membrane ruffles on non-polarized 
epithelial cells, where it associates with the F-actin cytoskeleton Alternatively, MDA5 
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localizes in the cytosol, with no visible co-localization with F-actin. Further observations 
have showed that RIG-I is capable of inducing cell migration within its association with 
F-actin and it also localizes at apical junction complexes in polarized epithelial or 
endothelial cells. The biological implications of the RIG-I – F-actin interaction are 
significant: it appears that depolymerisation of actin results in redistribution of RIG-I 
and subsequent activation of IRF3, NF-kB, and the IFN-β promoter activity (Mukherjee 
et al., 2009).  
Regarding its functions upon viral infection, RIG-I ligands encompass RNA 
molecules with two special features: (1) they possess a 5’ triphosphate (Hornung et al., 
2006) and (2) 5’ base pairing due to secondary RNA structures, such as hairpin 
conformations or panhandle structures (Schlee et al., 2009; Schmidt and Schwerd, 
2009).  
Studies targeting the characterization of molecular features of RIG-I ligands are 
largely based on in vitro transcripts [reviewed in (Schlee and Hartmann, 2010)]. In vitro 
RNA transcription by all the known RNA polymerases leaves a triphosphate at the 5’ 
terminal (pppRNA). Transfection of pppRNA in monocytes resulted in a robust 
secretion of IFN-α, while RNA without the triphosphate didn’t (Hornung et al., 2006). 
However, the 5’ triphosphate structure is not enough on its own to target a single 
stranded RNA (ssRNA) as nonself RNA and render it immunogenic – since studies 
revealed that 5’ triphosphate ssRNA  did not activated the RIG-I signaling (Schlee et 
al., 2009). Reverse cloning and sequencing of this ssRNA revealed the presence of 
sequences generated by self-coding intramolecular 3’ extensions that lead to a blunt-
ended RNA with complementary 5’and 3’ sequences (Schlee et al., 2009). Thus, these 
aberrant products of in vitro transcription are responsible for the immune-stimulatory 
properties of such preparations (Schlee et al., 2009). Alternatively to the 5´ base 
pairing, the composition of the RNA sequence may as well contribute to the stimulatory 
potential of pppRNA (Saito et al., 2008; Uzri and Gehrke, 2009). For example, the 
genomic ssRNA of Hepatitis C virus (HCV) is characterized by poly-uridine motifs with 
interspaced C nucleotides (known as poly-U/UC motifs), as well as a 5’ triphosphate 
(Saito et al., 2008; Uzri and Gehrke, 2009). Deletion of the poly-U/UC motifs abrogated 
the stimulatory activity of HCV (Uzri and Gehrke, 2009). Thus, both, the panhandle 
structures and poly-U/UC might serve as secondary PAMPs to pppRNA (Saito et al., 
2008; Uzri and Gehrke, 2009). 
 So far, the understanding of the molecular nature of MDA5 ligands is very poor. The 
common agonist for MDA5 is poly I:C, a synthetic molecule without a 5’ triphosphate 
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generated by annealing of poly-iosine strands to poly-citidine strands of variable sizes 
(Gitlin et al., 2006). Size fractionation of poly I:C revealed that MDA5 responds to high 
molecular weight poly I:C, while poly I:C with less than 1000bp acts as an agonist for 
RIG-I (Kato et al., 2008). In vitro assays using recombinant RIG-I and MDA5 showed 
that short and long poly I:C induce ATPase activity for RIG-I and MDA5, respectively 
(Kato et al., 2008). Consistent with this data, short dsRNA species (1.2-1.4 kbp) of 
reovirus genome selectively activated RIG-I, while longer dsRNA (~3.4 kbp) was able 
to activate MDA5 (Kato et al., 2008). These results strongly suggest that RIG-I and 
MDA5 discriminate short and long dsRNA; however, the underlying mechanism of the 
nucleotide length detection is yet to be discovered (Kato et al., 2008).  
All three highly related proteins that constitute the RLRs family ( RIG-I, MDA5 and 
LGP2) are presented at low levels in resting cells and its expression is strongly induced 
by type I interferons, creating a feed-forward feedback loop for a sustained antiviral 
response [reviewed at (Dixit and Kagan, 2013)]. 
RIG-I and MDA5 are DexD/H-box RNA helicases comprising two caspase activation 
and recruitment domains (CARDs) in their N-terminal – which are in fact the effector 
domains, responsible for signal transduction –  while LGP2 lacks CARDs (Saito et al., 
2007; Yoneyama et al., 2005) and reviewed at (Takeuchi and Akira, 2008; Yoneyama 
and Fujita, 2008). RIG-I and MDA5 share ~25% homology in their CARD regions and 
40% in their helicase domain (Yoneyama and Fujita, 2008); however, it was not well 
understood how nonself RNA was physiologically recognized, since none of these 
helicases has a RNA-binding domain. 
 
Figure 11 – Representation of the domains structures of RLRs and MAVS.  
Schematic representation of the domain features of the three RLRs. RIG-I and MDA5 hold two 
CARD domains while LGP2 lacks CARD domains at the N-terminus. All three RLRs contain an 
ATPase/helicase domain followed by the repressor domain (RD) at the C-terminus (CTD) – 
MDA5 RD-like domain doesn’t participate in auto-regulation. Adapted from: (Dixit and Kagan, 
2013) 
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RIG-I and LGP2 also have a repressor domain (RD, aa. 723-925), localized at the 
C-terminal domain (CTD) (Saito et al., 2007). The repressor domain is capable of 
interaction with the CARD and helicase (helicase linker region, aa. 420-627) domains, 
and overexpression of the repressor domain blocks the immediate RIG-I signalling 
(Saito et al., 2007). Thus, it was proposed an auto-repression model, in which the 
CARDs are masked through intramolecular interactions, mediated by the RD (Saito et 
al., 2007). 
The crystallographic structure of the repression domain reveals a zinc-binding 
domain, coordinated by four cysteines, also conserved in MDA5 and LGP2 (Cui et al., 
2008). Mutation studies show that this zinc-coordination site is a key structural motif, 
essential for RIG-I signalling; however, further studies are required in this matter (Cui et 
al., 2008). 
The C-terminal domain was recently described to partially overlap with the repressor 
domain, and the atomic structure of the former was determined by x-ray 
crystallography (Cui et al., 2008) and nuclear magnetic resonance (NMR) (Takahasi et 
al., 2008). One side of CTD exhibits a large cleft with positive surface charges and, the 
opposite side contains acidic patches (Takahasi et al., 2008). Adding dsRNA or 
5’pppRNA specifically titrates the NMR signal, suggesting that this cleft is, in fact, the 
RNA recognition surface (Takahasi et al., 2008). Consistent with this observation, 
mutagenesis at the cleft reduced the RNA binding and the signalling ability of RIG-I 
(Takahasi et al., 2008). Additionally, Cui et al. demonstrated, through filtration-gel 
analysis, that RIG-I CTD recognizes 5’pppRNA as a dimer, so, it is probable that one 
dsRNA molecule can simultaneously bind multiple CTD RIG-I molecules (Cui et al., 
2008). 
Functional studies suggest that CTD detains two distinct functions: the RNA 
recognition and signal repression. Mutagenesis in the concave cleft inactivated RNA 
recognition, but none of the mutations led to a permanently active RIG-I, suggesting 
that the RNA recognition and the RNA repression surfaces don’t overlap (Takahasi et 
al., 2008). Furthermore, ATP binding or its hydrolysis is not required to RNA 
recognition, suggesting a model of an inactive RIG-I, in which the repressor domain 
mediates a closed structure through intramolecular interactions, while the RNA-binding 
domain remains available (Cui et al., 2008; Saito et al., 2007; Takahasi et al., 2008). 
When a virus releases its dsRNA or 5’pppRNA, these PAMPs bind to the concave 
surface of the RNA-recognition site, inducing conformational changes in the presence 
of ATP, and, consequently, the CARDs are exposed (Takahasi et al., 2008). The freed 
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CARD domains form complexes with other molecules of RIG-I or with the protein 
adaptor MAVS (Mitochondrial AntiViral Signalling adaptor) for the progression of the 
downstream signal transduction (Cui et al., 2008; Takahasi et al., 2008).  
 
Figure 12 – Model of RIG-I activation by nonself RNA.  
In an inactive state, the RIG-I CTD overlaps with the repressor domain and interacts with the 
helicase domain and the CARD in the absence of its ligand. When viruses produce dsRNA or 
5’ppp-RNA, these nonself RNAs bind to the RNA-recognition cleft on the CTD and induce 
conformational changes in the presence of ATP, resulting in the exposure of the CARD. The 
released CARD becomes able to form complexes with either other RIG-I molecules or 
downstream adaptor MAVS to transduce biological signals (Yoneyama and Fujita, 2008). 
 
 
Unlike RIG-I and MDA5, the LGP2 role in antiviral immunity is less clear. LGP2 
lacks the CARD domain.(Rothenfusser et al., 2005; Yoneyama et al., 2005) Deployed 
of a signalling domain, LGP2 was proposed as a negative regulator of RLR signalling, 
since the overexpression of LGP2, in fact, does not activate induction of IFN-
β.(Rothenfusser et al., 2005) In vivo experiments with different lines of LGP2-defficient 
mice contradicted the previous data generated by in vitro studies, implicating LGP2 as 
a positive regulator (Satoh et al., 2010). In the absence of LGP2, the viral RNA 
responses through RIG-I and, particularly, through MDA5 were compromised while 
responses to synthetic ligands weren’t affected (Satoh et al., 2010). Presumably, LGP2 
facilitates the binding of viral RNA – potentially through protein complexes – to its 
receptor, while the affinity of RIG-I and MDA5 is strong enough to bind naked synthetic 
agonists (not bound to LGP2) (Satoh et al., 2010; Venkataraman et al., 2007). 
Structural analysis of the binding interface between RNA and the CTD supports this 
model, since it predicts a weaker affinity of MDA5 than RIG-I to its ligand (Takahasi et 
al., 2009).   
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Besides confirming the role of LGP2 as a positive regulator (although not essential 
to RLR signaling), a recent study implicated LGP2 as an intrinsic regulator of the 
survival of CD8+T virus-specific cells (Suthar et al., 2012). CD8+T cells are crucial to 
control the pathology of the West Nile virus in the brain. LGP2-defficient mice 
presented a higher viral burden and a significant reduction of West Nile virus-specific 
CD8+T cells, leading to a higher mortality rate when compared to wild-type animals 
(Suthar et al., 2012). In spite of these findings, further clarification is still necessary to 
establish the role of LGP2 in RLR signaling pathways. 
 
1.4.1.5 – Cytosolic DNA receptors 
While RLRs focus their actions against viral RNAs, very recently, other molecules have 
been found to act as cytosolic receptors capable of direct recognition of viral DNA. 
Among them, DAI (DNA-dependent activator of IFN-regulatory factor) was the first DNA 
cytosolic sensor described to induce type I IFN in response to dsDNA (Takaoka et al., 
2007). Several groups identified AIM2 (absent in melanoma 2) as a cytosolic dsDNA 
sensor, whose activation promotes the assembly of an inflammasome (Bürckstümmer 
et al., 2009; Fernandes-Alnemri et al., 2009; Hornung et al., 2009). A third cytosolic 
dsDNA sensor, LRRFIP1 (Leucine-rich repeat flightless-interacting protein 1) can 
recognize AT-rich B-form dsDNA as well as GC-rich Z-form dsDNA. Yang et al. 
demonstrated that LRRFIP1 triggers IFN-β production in a β-catenin-dependent 
manner (β-catenin binds to the C-terminal domain of IRF3, inducing an increase in IFN-
β expression) (Yang et al., 2010). Despite the discovery of these cytosolic DNA 
sensors and their ligands, their precise role in antiviral innate immunity remains elusive.  
 
Since a single pathogen can activate multiple PRRs, crosstalk between the different 
receptors might have a role in enhancing or inhibiting immune responses. Thus, the 
regulation of the PRR signaling is required in order to clear infectious pathogens and, 
at the same time, preventing an abnormal and excessive PRR activation that could 
lead to the development of auto-immune or inflammatory disorders.  
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1.5 – Cellular responses to viral infections: Interferons (IFNs) and Interferon-
stimulated genes (ISGs) 
1.5.1 - Interferons  
There is no definitive cure to viral infections and, most of the times, their outcome 
relies entirely on the ability of the immune system to recognize, restrain and eliminate 
the virus. Based on current evidences, it seems that the immune system employs 
essentially the same type of mechanism against the endless array of viruses. This 
mechanism relies on the actions of interferons (IFNs). This molecules are produced in 
infected cells and are capable of “warning” the neighbouring cells about the presence 
of a viral infection in course, so they can be better “prepared” to fight the infection (or 
even commit suicide through apoptosis), thus preventing the spread of the virus. To 
date, the key aspect for the establishment of an effective immune response relies on a 
robust production and secretion of IFNs in response to a given infection (Meager, 
2006).  
The interferon system is considered unspecific since several stimuli can induce the 
production of the same type of IFNs and the same type of IFNs inhibits several kinds of 
viruses. On the other hand, interferon can also possess very specific actions 
depending on the animal species in which they are induced (e.g.: IFNs protect human 
and monkey cells but not chicken cells) (De Andrea et al., 2002).  
Based on their amino-acidic sequence, their receptor specificity, chromosomal 
location, structure and physicochemical properties, interferons are grouped in three 
distinct classes, namely, type I , type II  and type III (Meager, 2006).  
The mammalian type I interferons include IFN-α (alpha), IFN-β (beta), IFN-κ 
(kappa), IFN-δ (delta), IFN-ε (epsilon), IFN-τ (tau), IFN-ω (omega), and IFN-ζ (zeta, 
also known as limitin). This repertoire of interferons is thought to signal through the 
surface receptor complex IFNAR that consists in two transmembrane chains IFNAR-1 
and IFNAR-2. However, not all type I interferons are expressed in humans; thus, the 
focus will be only upon IFN-α and -β, the first to be discovered and best characterized 
interferons (Meager, 2006). 
IFN-α is encoded in a cluster of genes on chromosome 9 in humans. It is a protein 
family that comprises around 13 subtypes that share 76-99% of their amino acid 
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identity, whose structure comprises 166 amino acids with no glycolisation sites and a 
stable pH – with the exception of IFN-α2a that has a deletion on position 44. The 
different subtypes are produced differentially, depending on the inducer or producing 
cell. They are induced in macrophages and lymphocytes under the stimulation by 
tumour or virus-infected cells as well as prokaryotic cells and mitogens (De Andrea et 
al., 2002; Meager, 2006).  
Unlike IFN-α, IFN-β is encoded by a single gene, also on chromosome 9 in humans. 
IFN-β proteins have a 166 amino acid sequence, sharing 40-50% of homology with 
IFN-α. They are expressed during myeloid differentiation and, as for IFN-α, in response 
to a given infection, particularly to Gram-negative bacterial infections (interestingly 
bacterial LPS doesn’t induce IFN-α) (Meager, 2006). 
Interferon-γ belongs to the type II class of interferons and is commonly known as 
the “immune” interferon. It is encoded on chromosome 12 and it is produced mainly in 
sensitized lymphocytes with the aid of macrophages and only under the action of 
mitogens. The IFN-γ protein has 166 amino acids with 23 of them representing a 
hydrophobic signaling sequence, with no analogy with IFN-α and –β (De Andrea et al., 
2002; Meager, 2006). 
Until 2003, the knowledge of immune responses to viruses was focused on type I 
and type II interferons; however, a new class of IFNs has been identified, the type III 
interferons. They comprise a family of proteins capable of inducing antiviral protection, 
designated by IFN-λ1, -λ2 and –λ3, alternatively, interleukins 29, -28A and -28B. 
Despite using a different receptor complex than type I IFNs, the main outcome is 
basically the same, resulting in the activation of Janus kinase (JAK)–Signal transducers 
and activators of transcription (STAT) signal transduction events, including the 
formation of IFN-stimulated gene factor 3 (ISGF3). A special feature of this class is that 
their actions are mainly limited to epithelial-like cells, providing antiviral protections only 
to certain tissues and organs (Meager, 2006). 
In spite of interferons being acknowledged by their potent antiviral action, they were 
also found to affect other vital cells and body functions. They can increase cell death in 
granulocytes, macrophages, natural killer and cytotoxic lymphocytes and interfere with 
the humoral immune response and the antigen/receptor expression. They can also lyse 
or inhibit the growth of certain cells, influence the differentiation and hormonal functions 
of epinephrine and adrenocorticotropin (ACTH). Interestingly, the effect of these 
modulations can also influence the outcome of viral infections (Albrecht et al., 1996). 
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1.5.2 – Interferon-stimulated genes 
The interferon system is famous for its ability to block viral replication and their 
effects are mediated by gene products whose expression is highly induced by 
interferons (Sen and Sarkar, 2007). These Interferon-stimulated genes (ISGs) were 
first discovered over 25 years ago, and, depending on cell type, interferon dosage, time 
of treatment, several microarray studies identified 50 to 1000 ISGs; In spite of these big 
numbers, only a small amount of action mechanisms of the ISG effector proteins were 
so far revealed. Collectively, ISGs aim at almost all steps of viral replication and 
present combinatory antiviral effects, acting synergistically to provide a powerful 
antiviral response. Some ISGs can even re-enforce antiviral effects inducing additional 
IFNs or ISGs (Schoggins and Rice, 2011). – refer to CHAPTER 2.4 for individual ISG 
action mechanisms. 
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2 – Mitochondria-dependent Antiviral Signalling – via the MAVS adaptor  
 
2.1 – Overview of the mitochondria-dependent antiviral pathway 
Mitochondria have been shown to be the key location for the signalling pathways 
initiated by RLRs. In fact, the mitochondrial antiviral signalling adaptor (MAVS), 
primarily localized in the mitochondrial outer membrane, has been characterized as a 
RIG-I binding protein (Ohta and Nishiyama, 2011). 
Upon RNA virus infection, the RIG-I helicase domain senses RNA-specific 
structures, inducing conformational changes and exposure of CARD domains, which 
are then submitted to polyubiquitination by TRIM25 at Lys172 (Gack et al., 2007). This 
conformational change mediates the dimerization of RIG-I through CARD interactions 
and subsequent binding to MAVS, which, in turn, dimerizes to generate a signalling 
scaffold (Gack et al., 2007). The RIG-I – MAVS interaction leads to the recruitment of 
members of the TRAF (Tumour Necrosis Factor (TNF) Receptor-Associated Factor) 
adaptor family, resulting in the parting of the signalling pathway in two: the antiviral IFN 
response, mediated by TRAF3, or the inflammatory response, mediated by TRAF2 and 
TRAF6 (Figure 13) (Saha et al., 2006; Seth et al., 2005; Xu et al., 2005).   
The type I IFN induction is mediated by an initial complex, consisting of TRAF3, 
NEMO (NF-κB Essential Modulator, also known as IKK-γ [Inhibitor of κB kinase, 
gamma subunit]) and TANK (TRAF family member-associated NF-kB activator). This 
complex controls the kinase activity of TBK1 (TANK-binding kinase 1) and IKKε 
(Inhibitor of κB kinase, epsilon subunit), which, specifically, phosphorylates the 
interferon regulatory factors IRF3 and IRF7, leading to their dimerization, nuclear 
translocation, and transcriptional activation of type I IFN genes (Belgnaoui et al., 2011). 
On the other hand, TRAF2 and TRAF6, in cooperation with RIP1 (Receptor-
Interacting Protein 1), activate the canonical kinase complex – IKKα, IKKβ and NEMO 
– resulting in the phosphorylation of IκBα at its Ser32/36 residues, leading to the 
ubiquitin-dependent proteasomal degradation of IκBα. IκBα is a regulatory protein that 
inhibits NF-kB by complexing with, and trapping it in the cytoplasm. The release of 
DNA subunits of NF-kB results in the nuclear activation of specific NF-kB target genes 
which regulate inflammatory responses (Belgnaoui et al., 2011). 
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Figure 13 – Schematic representation of the 
RIG-I signalling pathway.  
Upon detection of viral RNA with specific 
structure features (short dsRNA or 5’-
pppRNA) RIG-I is subject of protein unfolding 
(exposing the CARD domains), CARD 
ubiquitination by TRIM25 and interaction with 
MAVS that is bound to the mitochondrial 
outer membrane through its transmembrane 
domain. MAVS dimerizes (forming prion-like 
aggregates at the surface of mitochondria) 
and recruits adaptor proteins which are 
responsible for the activation of the 
transcription factors NF-kB, IRF3 and/or 
IRF7. The NF-kB branch of this pathway is 
induced via the recruitment of TRAF2/6 and 
RIP1, which triggers the activation of the IKK 
complex (NEMO/IKKα/IKKβ) that in turn is 
responsible for the phosphorylation of the NF-
kB inhibitor IκBα, causing its proteasomal 
degradation. Phosphorylation of this 
repressor releases NF-kB, promoting its 
nuclear translocation. The IFN branch of the 
RIG-I pathway is carried out by the interaction 
of TRAF3 with MAVS, which leads to the 
recruitment of the TANK/NEMO/IKKε/TBK1 
complex, which is accountable for the 
phosphorylation, dimerization and nuclear 
translocation of IRF3 and/or IRF7. IRF3 and 
IRF7 dimers bind to ISREs (Interferon-
Stimulated Response Elements) promoters to 
ultimately induce the expression of IFN-
stimulated genes. Text adapted from: 
(Belgnaoui et al., 2011)  
 
 
Universidade de Aveiro                                             Mitochondria and Peroxisomes: role within  
cellular antiviral defense 
 
  
Mariana Guedes   49 
 
 
Both, IRFs and NF-kB bind to the IFN-β promoter in a temporary coordinated 
fashion to carry on its transcription. In turn, the secreted IFN-β binds to and activates 
the type I IFN receptor in an autocrine or paracrine manner. The receptor-ligand 
interaction induces the activation of the JAK-STAT pathway and formation of ISGF3 
(IFN-stimulated gene factor 3), which translocates to the nucleus and induces the 
transcription of hundreds of ISGs (Interferon Stimulated Genes) involved in the 
generation of an antiviral state (Belgnaoui et al., 2011).  
Many ISGs function as direct antiviral effectors that prevent the viral genome 
replication, virion assembly or release from the infected cells. Others encode signalling 
pathways components such as PRRs or transcription factors in order to enhance the 
IFN response, thus creating a positive feedback loop, amplifying the antiviral response 
(Dixit and Kagan, 2013). 
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2.2 – Viral interaction with RIG-I/MDA-5 and subsequent recruitment of MAVS 
adaptor 
2.2.1 – Activation of RIG-I by viral genomes and proximal signal 
transduction  
The RLR activation is a multistep process that requires a well-coordinated 
interaction between receptor, ligand and several accessory proteins. Contrarily to RIG-
I, the requirements for an efficient MDA5 activation are yet to be clarified, but it seems 
reasonable to assume that both follow a similar mechanism.  
Taking RIG-I as an example, the knowledge of this process, to date, involves the 
following chain of events (as proposed by (Dixit and Kagan, 2013) review): 1 – in 
resting-state cells, RIG-I adopts a closed conformation, resulting in an auto-inhibitory 
state (no signaling); 2 –  pppRNA binds to RIG-I and induces conformational changes 
that lead to dimerization and exposure of CARDs in an open conformation; 3 – 
phosphorylation events of RIG-I and TRIM25-dependent ubiquitination activate the 
signalling ability of RIG-I; 4 – RIG-I associates with MAVS, in a CARD-dependent 
manner; 5 – MAVS accumulates in signalling aggregates by a prion-like mechanism.  
In the absence of infection, RIG-I is kept in an auto-inhibited state by intramolecular 
interactions between CARDs and helicase domains that hinders the RNA binding to the 
helicase domain and prevents CARDs from signalling (Kowalinski et al., 2011; Saito et 
al., 2007). When overexpressed, the N-terminal of RIG-I comprising the two CARDs 
adopts a constitutively active conformation, but, in physiologic conditions, the closed 
conformation only opens upon binding of the ligand at the C-terminus to facilitate the 
downstream signalling through CARDs (Kowalinski et al., 2011; Yoneyama et al., 
2004).  
Crystallographic structures of RIG-I present a detailed vision of the conformational 
changes triggered by the ligand binding, which are required to the signal initiation 
(Kowalinski et al., 2011; Luo et al., 2011). Structural data suggest a model where, in an 
auto-repressed state, the CTD is deprived of intramolecular interactions and can freely 
engage the binding of pppRNA (Kowalinski et al., 2011). This initial event increases the 
local RNA concentration and leads to a cooperative RNA and ATP binding to the 
helicase domain, resulting in dramatic rearrangements within the helicase domain 
(Kowalinski et al., 2011). The helicase domain and the CTD completely surround the 
RNA, anchoring themselves to the helix through a number of intramolecular 
interactions (Luo et al., 2011). This newly formed channel comprises 9 to 10 bp along 
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the RNA; longer RNAs allow the binding of two monomers of RIG-I, simultaneously 
(Kowalinski et al., 2011). However, this apparent dimerization lacks a protein-protein 
interface, reflecting instead an oligomerization guided by RNA (Kowalinski et al., 2011).  
 
Figure 14 – Model of RIG-I activation by short dsRNA and/or 5’ppp ssRNA.  
A) RIG-I, in its inactive state is found with a closed structure with the CARD repressed by, 
presumably, interactions between the CTD and helicase linker region. B) Upon viral infection, 
short dsRNA or 5’pppRNA activates RIG-I in the presence of ATP. C) Longer dsRNAs (like poly 
I:C) might interact with CTD and the helicase domain of RIG-I, allowing the formation of a stable 
complex that induces a distinct conformation of RIG-I (Takahasi et al., 2008). 
  
The propagation of the signalling pathway through ligand-activated RIG-I is 
accomplished by the N-terminal CARDs (Yoneyama et al., 2004). Deletion of CARDs 
results in a dominant negative phenotype (Yoneyama et al., 2004). Take the following 
example: Huh7.5 cells, a subpopulation of Huh7 hepatocyte cell line, which is 
characterized by a mutation of threonine by an isoleucine in the position 55 (T55I) at 
the first CARD of RIG-I, failed to respond to HCV infection (Sumpter et al., 2005). As a 
consequence, the absence of a functional antiviral activity generated conditions for 
HCV replication in Huh7.5 cells (Sumpter et al., 2005). The T55I mutant interferes with 
the ubiquitin-ligase E3 TRIM25, which is necessary for the activation of RIG-I signalling 
(Sumpter et al., 2005).  
Gack et al. reported that TRIM25 binds to the first CARD through its SPRY domain 
(Gack et al., 2007). A pre-requisite for TRIM25 is the phosphorylation of RIG-I at T170 
by a (not yet identified) phosphatase (Gack et al., 2010). A phosphomimetic mutation of 
T170 jeopardized the TRIM25 binding to RIG-I and, subsequently, interfered with 
downstream signalling events (Gack et al., 2010). TRIM25 transfers ubiquitin fragments 
bound to K63 in lysine 172 (K172) at the second CARD, using its RING domain and 
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oligomerization of RIG-I with the MAVS adaptor depends critically upon this 
modification (Gack et al., 2007). Accordingly, TRIM25-defficient MEFs (Mouse 
Embryonic Fibroblasts) can’t secrete IFN-β after infection with Sendai virus (Gack et 
al., 2007; Jiang et al., 2012). Despite the fact that TRIM25 does not bind ubiquitin 
fragments to MDA5, a poly-ubiquitin binding by MDA5 is necessary for its signalling 
functions (Jiang et al., 2012).  
The need of RIG-I ubiquitination for the initiation of the downstream signalling was 
challenged by a study using a cell-free system, to identify the minimal components 
necessary for the signal transduction (Zeng et al., 2010). The RIG-I pathway was 
reconstituted by a mix containing affinity-purified RIG-I, raw mitochondria and 
peroxisomes (containing the adaptor MAVS), cytosolic extracts (containing TBX1), in 
vitro synthesised IRF3 and ATP. The RIG-I activity was quantified by the measurement 
of the IRF3 dimerization, a readout for its activation. In this in vitro assay, the authors 
reviewed key aspects of the RIG-I signalling and revealed new regulatory mechanisms. 
The IRF3 activation required MAVS and TRIM25, while depletion of these proteins by 
RNAi interfered with IRF3 dimerization. RIG-I needed to be isolated from virus-infected 
cells in order to be activated by in vitro RNA or to be present under the form of a N-
terminal CARD fragment for the IRF3 activation to occur. The ubiquitination factory, 
responsible for RIG-I activation, showed to comprise E1, E2 Ubc5, Ubc13 and E3 
TRIM25, once the mitochondrial fraction of infected cells with depletion of Ubc5 
(isoform b and c) and Ubc13 no longer raised IRF3 dimerization. Thus, the TRIM25 
requirement and K63-bound ubiquitin for the IFN-β induction by RIG-I was confirmed in 
this experimental context (Zeng et al., 2010). 
As a consequence of the initial antiviral events (viral-RNA binding  RIG-I activation 
 CARDs ubiquitination) as previously described, RIG-I turn into an adequate 
complex, capable of inducing a powerful downstream signalling cascade through its 
interaction with the mitochondrial antiviral signalling (MAVS) adaptor. 
  
2.2.2 – MAVS Interactome/Signalosome 
The MAVS adaptor, comprising 540 amino acids, in Homo sapiens, is an external 
membrane protein with a predicted molecular weight of ~56kDa (Kawai et al., 2005; 
Meylan et al., 2005; Seth et al., 2005; Xu et al., 2005). MAVS is coded at the nuclear 
genome and it is ubiquitously expressed in a variety of cells lines and tissues (Kawai et 
al., 2005; Meylan et al., 2005; Seth et al., 2005; Xu et al., 2005). 
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Structurally, MAVS has a CARD domain in its amino terminal (aa. 10 to 77), a 
proline-rich region (PRR; aa. 107 to 173) and a C-terminal transmembrane domain 
(CTD; aa. 514 to 535) that anchors MAVS to the outer mitochondrial membrane (Seth 
et al., 2005). MAVS also comprises two TRAF-interacting motifs (TIMs) at the proline-
rich region: one of them localizes at aa. 143-147 and binds TRAF2, and the second 
one localizes at aa. 153-158 binding TRAF6 (Seth et al., 2005; Xu et al., 2005). An 
alternative TRAF6-binding site is also located at the C-terminal (aa. 455-460), and both 
TIMs at the PRR and carboxyl terminal are required for the NF-kB activation mediated 
by TRAF6 (Xu et al., 2005). It was recently demonstrated that the C-terminal TIM of 
MAVS also binds to TRAF3 and exclusively mediates the induction of IFN and ISG 
expression (Paz et al., 2011; Saha et al., 2006).  
 
Figure 15 – Schematic representation of Mitochondrial Antiviral Signalling protein. 
In accordance with (Seth et al., 2005); TM – Transmembrane domain; N- amino terminal; C- 
Carboxil terminal 
 
 
The initial identification of MAVS was achieved by four independent groups, almost 
simultaneously (Kawai et al., 2005; Meylan et al., 2005; Seth et al., 2005; Xu et al., 
2005). One group used a cloning strategy to identify activating molecules of IFN-β 
promoter and ended up isolating a gene, whose protein they named IFN-β Promoter 
Stimulator-1 (IPS-1) (Kawai et al., 2005). A second group isolated the same protein by 
screening of non-characterized proteins known as powerful NF-kB inducers; they 
named their protein as VISA – Virus-Induced Signalling Adaptor (Xu et al., 2005). Two 
other groups conducted research profiles at human proteins databases to identity novel 
proteins containing CARD domains, similar to those found at RIG-I and MDA5; they 
called the resulting products Cardif (CARD adaptor inducing IFN-β) and MAVS 
(mitochondrial antiviral signalling adaptor) (Meylan et al., 2005; Seth et al., 2005). 
The precise space-time events that involve MAVS adaptor in viral infections are still 
under intense investigation. Although several studies portray adaptor molecules that 
interact with MAVS, it is unlikely that all of them have a physiological role at the MAVS 
mediated signalling [MAVS interacting partners can be reviewed in (West et al., 2011)]. 
However, given their physiological importance in the innate immune response to viral 
infection, some of the components of MAVS interactome already mentioned in this 
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chapter will be further analysed here, and a few more components will now be 
introduced. 
 
 
 
Figure 16 – Focusing on the Mitochondria: antiviral signalling pathways. 
Cytosolic viral RNA is recognized by the RIG-I-like receptors (RLRs) RIG-I and MDA5, which 
activate MAVS through CARD-CARD interactions. MAVS then recruits various signalling 
molecules to transduce downstream signalling such as TRAF6 and TRAF5. TRAF6 along with 
TRADD activates canonical NF-kB signalling via RIP1 and FADD. Canonical NF-kB signalling 
occurs as the IκB kinase (IKK) complex – consisting of IKKα, IKKβ and IKKγ (a.k.a. NEMO) – 
phosphorylates the NF-kB inhibitor IκBα, resulting in the proteasomal degradation of IκBα and 
thus liberating NF-kB to translocate into the nucleus and initiate pro-inflammatory cytokine gene 
expression. MAVS also interacts with various molecules that activate IRF signalling (such as 
STING). These molecules, together with the TRAP complex and the SEC61 translocon mediate 
the activation of TBK1, which phosphorylates IRF3 and IRF7. In addition, MAVS interacts with 
TOM70 which, in turn, interacts with HSP90 and thereby localizes TBK1 and IRF3 in proximity 
to the MAVS signalosome. Finally, MAVS binds to TRAF2 and TRAF3 and through TRADD and 
TANK/NAP1 promotes IKKε- and TBK1-mediated phosphorylation of IRF3. This promotes IRF3 
nuclear translocation, leading to the expression of type I interferon genes. Adapted from: (West 
et al., 2011) 
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TRAF3: The MAVS regulation of type I IFN induction is accomplished by direct and 
specific interaction between the TRAF domain of TRAF3 and a TRAF interaction motif 
of MAVS itself (TIM) (Saha et al., 2006; Tang and Wang, 2009). Point mutations in two 
critical amino acids (Y440A/Q442A) in the TRAF domain of TRAF3 prevented the 
association with MAVS and completely ablated the TRAF3-dependent IFN production, 
after viral infection (Saha et al., 2006). Additionally, TRAF3 knockout cells showed a 
pronounced reduction in IFN-α production, indicating its crucial role in RLR signalling 
(Saha et al., 2006). After TRAF3 recruitment to the signalling complex, the RING 
domain of TRAF3 – responsible for its E3 ubiquitin ligase activity – assembles Lys63 
polyubiquitin chains, thus creating a scaffold for the assembly of a signalling complex 
made of IKKε and TBK1, leading to the activation of IRF3 and IRF7 ([reviewed at (West 
et al., 2011)]. 
TRAF2 and TRAF6: Similarly to TRAF3, TRAF2 and TRAF6 interact with MAVS (Xu 
et al., 2005). Although the binding of TRAF6 to MAVS has been demonstrated, the role 
of TRAF6 in IFN-α/β production is not fully understood. A recent report showed that 
NF-kB, JNK (c-Jun N-terminal kinase) and p38 mitogen-activated protein kinase 
activation was compromised in TRAF6-deficient MEFs in response to vesicular 
stomatitis virus (VSV) and poly I:C (Yoshida et al., 2008). Furthermore, this study 
suggested that MAVS requires TRAF6 and MEKK1 (mitogen-activated protein (MAP) 
kinase/extracellular signal-regulated protein kinase (ERK) kinase 1) to activate NF-kB 
and mitogen-activated protein kinases (MAPKs) to achieve an optimal type I IFN 
induction (Yoshida et al., 2008). In line with the role of TRAF6 in the RIG-I signalling, 
myeloid dendritic cells and fibroblasts, upon Sendai virus (SeV) infection, mediate the 
activation of the p38 MAPK, via TRAF2 and TAK1 (aka. Mitogen-activated protein 
kinase kinase kinase 7); the p38 MAPK activation, in turn, promoted the IL-12 
production and increases the type I IFN induction (MIKKεlsen et al., 2009).   
TANK and NAP-1: Both, TANK (TRAF-family member associated NF-kB activator) 
and NAP-1 (NF-kB-activating kinase-associated protein 1) are adaptor proteins 
involved in IRF activation in response to a viral infection (Guo and Cheng, 2007). TANK 
acts as a scaffolding protein with multi-domains that gathers elements of the IRF and 
NF-kB pathways, promoting the activation of both, the IKK complex and the IKK related 
kinases (Guo and Cheng, 2007). NAP-1 is an ubiquitous cytoplasmic protein that 
interacts with IKKε and TBK1, facilitating the IRF3 activation and induction of IFN-β 
after VSV infection (Sasai et al., 2006).  
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NEMO: Known as a regulatory subunit of the classical IKK complex, NEMO serves 
as a bridge for the NF-kB and IRF signalling pathways, promoting cross-talk between 
these pathways during RIG-I signalling to activate IFNs (Zhao et al., 2007). NEMO acts 
downstream of MAVS and interacts with TANK to mediate the recruitment of TBK1 and 
IKKε to the RIG-I – MAVS complex (Zhao et al., 2007). NEMO mutants, lacking the 
TANK-binding domain, fail to interact with IKKε, TBK1 and MAVS mediated signals 
(Zhao et al., 2007). 
FADD, RIP1, TRADD and Caspases 8 and 10: Interestingly, FADD (Fas-
associated death domain) and RIP1 (receptor interacting protein 1) have also been 
implicated in the antiviral pathway (Balachandran et al., 2004). These death domain 
containing molecules interact with MAVS C-terminal, inducing NF-kB through 
interaction and activation of caspases 8 and 10 (Takahashi et al., 2006). Both 
caspases are cleaved during dsRNA stimulation and overexpression of the cleaved 
form of these caspases is enough to activate NF-kB (Takahashi et al., 2006). In 
addition, caspase 8-deficient mouse derived cells showed reduced expression of 
inflammatory cytokines and NF-kB, illustrating the importance of these caspases in the 
NF-kB branch of the RIG-I signalling (Takahashi et al., 2006). Moreover, TRADD 
(Tumour necrosis factor receptor type 1-associated death domain), a fundamental 
adaptor of the TNFR-I (tumour necrosis factor receptor-1), has been showed to be 
recruited to MAVS, upon viral infection, coordinating the assembly of a signalling 
complex comprising TRAF3, TANK, FADD and RIP1, leading to IRF3 and NF-kB 
activation (Michallet et al., 2008)– see Figure 16 above. 
STING: The recent discovery of a novel protein, named stimulator of interferon 
genes (STING) brought a new component to the antiviral pathway (Ishikawa and 
Barber, 2008; Jin et al., 2008; Zhong et al., 2008). STING, comprising four 
transmembrane domains, was shown to be expressed at the external mitochondrial 
membrane and the binding of nucleic acids to RIG-I triggered the formation of a 
complex between MAVS and STING, conducting to the TBK1 recruitment and 
subsequent phosphorylation of IRF3 (Zhong et al., 2008). Conversely, the Barber 
group reported STING to be localized at the endoplasmic reticulum (ER) membrane 
through its transmembrane domains (Ishikawa and Barber, 2008). Although STING 
interacts directly with RIG-I, it was not able to co-immunoprecipitate with MDA5 or to 
respond to the poly I:C mediated IFN activation (Ishikawa and Barber, 2008). Other 
reported differences show that STING co-immunoprecipitates with TRAP complex 
components (TRAPβ - Target of RNAIII-activating protein beta) and the translocon 
adaptor SEC61β, whose cellular functions involve translocation of proteins through the 
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ER membrane, after translation (Ishikawa and Barber, 2008). This observation lead the 
authors to suggest that STING can bind RIG-I to the translocon, in order to detect 
translating viral RNAs to induce antiviral immunity through TBK1 (Ishikawa and Barber, 
2008). Jin et al. localized a similar molecule, named MPYS, in both, mitochondria and 
the plasma membrane, and found an alternative function, where MPYS associates with 
the major histocompatibility complex class II (MHC II) and mediates apoptotic signal 
transduction (Jin et al., 2008). A full understanding of the role of STING/MPYS/MITA in 
innate immune signalling awaits further investigation.  
 
 2.2.3 – Posttranslational Modifications of MAVS 
As mentioned in the beginning of this chapter, MAVS accumulates in the cell, in 
signalling aggregates, by a prion-like mechanism (Hou et al., 2011). Recent studies 
defined these aggregates as highly organised fibrils, self-replicating, like prions. Using 
a cell-free system to reconstitute RLR signalling in vitro, MAVS complexes, bigger than 
26S proteasome were detected 9h after SeV infection, which coincided with IRF3 
dimerization (Hou et al., 2011). These complexes present several prion features:  (1) 
MAVS-CARD is required and it is enough for the formation of the fibril-like structures, 
as it was determined by electronic microscopy; (2) these fibrils are resistant to protease 
treatment and detergent solubilisation; (3) the protease resistant fibrils convert MAVS 
of mitochondria extracted from non-infected cells, into functional aggregates, leading to 
IRF3 activation (Hou et al., 2011). On the other hand, mitochondria lacking MAVS, 
generated by RNAi previous to the extraction, didn’t result in IRF3 dimerization (Hou et 
al., 2011). Importantly, MAVS aggregates form within minutes after RLR signal 
activation in the cell-free reconstitution, indicating that these MAVS fibrils are a bona 
fide determinant of the activated state of MAVS. 
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Figure 17 – MAVS forms prion-like aggregates when induced by RIG-I.  
The interaction between CARD domains of RIG-I and MAVS induces a conformational change 
of the MAVS CARD, which in turn converts other MAVS on the mitochondrial outer membrane 
into prion-like aggregates. These aggregates activate cytosolic signalling cascades that turn on 
NF-kB and IRF3, leading to the induction of type I IFNs and other antiviral molecules (Hou et al., 
2011). 
 
 
Ubiquitination represents an important posttranslational modification of the proteins 
of the host cell, and the list of ubiquitinated proteins in RIG-I pathway is already 
extensive, demonstrating the relevance of this modification in the regulation of IFNs 
(Ribet and Cossart, 2010).  
MAVS is ubiquitinated upon viral infection and studies show that K48 and K63 
polyubiquitination occurs in virus-infected cells (Paz et al., 2009). Furthermore, 
polyubiquitination at lysine500 of MAVs leads to the recruitment of IKKε to MAVS and 
contributes to the negative regulation of IFN signalling by dislodging TRAF3 (Paz et al., 
2009). 
Several E3 ligases and proteins have been identified to contribute to the turnover of 
MAVS after viral infection: You et al. demonstrated that PCBP2 (Poly(rC)-binding 
protein 2) recruits the E3 ligase AIP4 (atrophin-1-interacting protein 4) to catalyse the 
K48 polyubiquitination and degradation of MAVS; Zhong et al. identified the E3 ligase 
RNF5 (ring finger protein 5) as another ligase that targets MAVS to ubiquitination and 
degradation (F. You et al., 2009; Zhong et al., 2010). In the latter study, Lys362 and 
Lys461 were identified as the K48 acceptor sites, which lead to proteasomal 
degradation of MAVS, upon viral infection (Zhong et al., 2010). Arimoto et al. identified 
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RNF125 (ring finger protein 125) as negative regulator of RIG-I pathway through a 
mechanism mediated by E2 ligase UbcH8 (a.k.a. UBE2L6 - Ubiquitin/ISG15-
conjugating enzyme E2 L6) (Arimoto et al., 2007). Taken together, these studies 
provide evidence that the MAVS degradation is an important mechanism, employed by 
the cell to turn off the antiviral IFN response. 
The negative regulation of MAVS signalling was also associated with 
phosphorylation. PLK1 (Polo-like kinase 1) was also identified as a MAVS partner, 
using yeast two-hybrid assays (Vitour et al., 2009). PLK1 associates with two discreet 
domains of MAVS, in a phosphorylation-dependent or independent manner (Vitour et 
al., 2009). The phosphodependent binding to MAVS requires phosphorylation at 
threonine 234 (Vitour et al., 2009). However, PLK1, as a negative regulator of MAVS, is 
independent of phosphorylation events and requires the binding of PLK1 to the MAVS 
C-terminal; this association disrupts the interaction of MAVS with TRAF3 (Vitour et al., 
2009).   
It has been showed that MAVS can be phosphorylated in the presence of IKKε, but 
not in the presence of TBK1, and the disruption of the MAVS – IKKε interaction, by 
point mutation at Lys500 of MAVS, diminishes, but doesn’t completely abolish 
phosphorylation, suggesting other kinases to be involved in MAVS phosphorylation 
(Paz et al., 2009). A study by Johnsen et al. demonstrated that tyrosine-kinase c-Src 
augments the RIG-I mediated signalling at the level of TRAF3, although c-Scr can also 
interact with other components such as RIG-I and MAVS and, thus, participates in the 
formation of the innate signalling complex (Johnsen et al., 2009). c-Scr acts with MAVS 
and TRAF3 in the activation of IRF3, but the possibility of c-Scr directly phosphorylate 
MAVS, TRAF3 or RIG-I is yet to be determined (Johnsen et al., 2009). The non-
receptor kinase protein like c-Scr, c-Abl has also showed to interact with, and 
phosphorylate MAVS, in order to regulate the immune response upon viral infection 
(Song et al., 2010). The same way as other adaptor proteins, the transmembrane and 
the CARD domain of MAVS are necessary for the interaction with c-Abl (Song et al., 
2010). Further studies are necessary to delineate the specific sites of 
interaction/phosphorylation, as well as the physiological role of phosphorylation in this 
context (Song et al., 2010). 
Like most of posttranslational modifications, phosphorylation is a reversible process, 
which involves the activity of phosphatase proteins. In this regard, the threonine-
phosphatase EY4A was showed to interact with NLRX1 and STING, thus 
demonstrating their role in MAVS interactome (Okabe et al., 2009). Although several 
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studies have been demonstrated that MAVS is phosphorylated, there is no clear 
evidence of the relevance of this posttranslational modification for the IFN signalling or 
to the general outcome of viral infection. 
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2.3 - Host regulatory mechanisms of the virus – RIG-I/MDA5 – MAVS interface  
The RLR signalling pathway is under tight control by a number of mechanisms to 
prevent an aberrant interferon production. The limitation of the IFN production is a 
physiological requirement for the general well-being of the organism. Upon initiation of 
antiviral responses, a restriction of the excess IFN production must occur. Therefore, 
several regulatory mechanisms take place to control the IFN levels, confirming the 
importance of counteracting the deleterious effects of IFNs, which include chronic 
cellular toxicity and the development of inflammatory or auto-immune diseases 
(Komuro et al., 2008; Loo and Gale, 2011; Ramos and Gale, 2011). 
The first described regulatory mechanism was possible by the identification of a 
repressor domain within RIG-I and LGP2, which auto-regulates the RLR functions via 
dynamic intramolecular interactions(Komuro and Horvath, 2006; Rothenfusser et al., 
2005; Saito et al., 2007; Yoneyama et al., 2005). LGP2 itself was found to play a role 
as positive and negative regulator of the RLR signalling pathway. Recent studies 
showed that, whereas LGP2-/- MEFs are more susceptible to IFN production 
stimulation in response to synthetic RNA (poly I:C), and LGP2-/- mice are more 
resistant to the lethal virus VSV,  LGP2-/- cells/mice have a defective IFN production in 
response to EMCV (Satoh et al., 2010; Venkataraman et al., 2007). These apparently 
incongruent observations suggest that RIG-I may in fact be a target for the regulation of 
LGP2-mediated IFN production. The observed differences in LGP2 regulatory functions 
may be due, in part, to distinctions of genetic background of the mice lines, as well as 
the nature of each construct used to make the null LGP2 lines (Satoh et al., 2010; 
Venkataraman et al., 2007).  
LGP2 has also been reported as a negative regulator of MAVS, through its direct 
interaction with MAVS at the mitochondrial membrane (Komuro and Horvath, 2006). 
This prevents the vital association of MAVS with IKKi (a.k.a. IKKε) for downstream 
signal propagation through IRF3 (Komuro and Horvath, 2006).  
The regulatory functions of LGP2 are still to this date unclear and controversial 
between research groups and further work is required to determinate in which step of 
the RLR pathway LGP2 exerts its regulatory effects.  
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The regulatory mechanisms that will be further discussed in this chapter can be divided 
in three main categories: (1) Regulation by protein-protein interactions (where the 
previously described LGP2 regulation is included), (2) regulation by posttranslational 
modifications of components and cofactors of the RLR signalling pathway and (3) 
regulation via organelle dynamics.  
 
Figure 18 – RLR signalling cascade and its regulating partners. 
Several cellular factors known to contribute to regulation of multiple stages of RLR signalling are 
depicted in the figure. LGP2 is the third member of the RLR family of proteins with contradicting 
roles in the RLR signalling pathway. IFIT3, NLRX1 and Tom70 are mitochondrial-localized 
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proteins which interact directly with MAVS. Factors involved in ubiquitin mediated regulation are 
denoted in green text; factors which require direct interaction with RLR signalling components 
are depicted in blue text. 
 
  
 
 2.3.1 – Regulatory protein interactions 
Regulation of the RLR signalling components via protein interactions serves as one 
of the control mechanisms of the RLR response to a given viral infection. This 
regulation is mainly achieved through negative feedback, in order to regulate the levels 
of IFN production in later states of the cellular immune response, but there are also a 
few positive feedback mechanisms.  
In fact, ZAPS protein (zinc finger antiviral protein shorter isoform) directly associates 
with RIG-I in a ligand-dependent manner to potentiate and amplify downstream 
signalling events, such as IRF3 and NF-kB activation and type I IFN induction 
(Hayakawa et al., 2011). Additionally, tyrosine kinase s-Scr interacts with MAVS, TBK1 
and TRAF3, likely within the MAVS signalosome to enhance RLR-dependent IFN 
induction (Johnsen et al., 2009).  Separately, c-Abl (Src-like non-receptor protein 
kinase) has been showed to interact with, and phosphorylate MAVS during viral 
infection, to facilitate both signalling of IRF3 and NF-kB (Song et al., 2010). Besides, 
EYA4 (Eyes Absent 4) and its phosphothreonine-specific phosphatase activity are 
required to facilitate IFN signalling. EYA4 has been reported to interact with MAVS, 
STING and NLRX1, more likely within MAVS signalosome (Okabe et al., 2009). 
The mitochondrial protein Tom70 (Translocase of outer membrane 70) has been 
identified, through mass spectrometry and immunoprecipitation, as a novel MAVS-
interacting partner (Liu et al., 2010). Tom70 is a member of the TOM complex at the 
outer mitochondrial membrane that recognizes newly synthesised mitochondrial 
proteins at the cytosol and has a role in the translocation of such proteins to their 
destination within the mitochondria [reviewed at (Baker et al., 2007)]. Exogenous 
Tom70 potentiated IFN-β induction in response to SeV and cytosolic poly I:C 
stimulation, while its depletion by RNAi resulted in an abrogated IFN-β induction to the 
same stimuli (Liu et al., 2010). MAVS and Tom70 interaction was enhanced in 
response to SeV infection and poly I:C and it requires the mitochondrial localization of 
both proteins (Liu et al., 2010). Based in previous works by the same group showing 
that chaperone protein Hsp90 was constitutively complexed with IRF3/TBK1 (Yang et 
al., 2006), and other studies showing that Hsp90 interacts with Tom70 (Young et al., 
2003), the authors proposed the hypothesis that Tom70 can be involved in the 
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recruitment of IRF3/TBK1 to MAVS to enable signalling (Liu et al., 2010). In fact, 
immunoprecipitation experiments confirmed that exogenous Hsp90 bound to Tom70 
and IRF3/TBK1 and exogenous Tom70 interacts with Hsp90 and IRF3/TBK1 (Liu et al., 
2010). The results of these studies taken together proposed a model in which Tom70 
interacts with MAVS and recruits both, IRF3/TBK1 and IKK complexes to mitochondria, 
by specifically recognizing and interacting with Hsp90, thus linking MAVS to 
downstream signalling.(Liu et al., 2010)    
Other studies have demonstrated that ISGs can also regulate MAVS to influence 
signalling. The IFIT3 protein (IFN-induced protein with tetratricopeptide repeats 3) is an 
ISG and represents a candidate to positive feedback in RLR signalling, via MAVS 
interactions (Liu et al., 2011). The IFIT proteins are known for being highly inducible by 
viral infections and IFNs. IFIT3 localizes at mitochondria, where it interacts with both 
MAVS and TBK1. Overexpression of IFIT3 potentiated RLR signalling, while its 
depletion reduced it. IFIT3 probably acts as a scaffold to favour MAVS interaction with 
TBK1, since this interaction is weak in the absence of IFIT3 and reinforced in its 
presence. Thus, this study added IFIT3 to the list of positive regulators of MAVS 
signalosome and found a novel role of IFIT3 in the antiviral signalling (Liu et al., 2011). 
Conversely, a greater number of protein interactions acts as negative feedback 
regulatory factors. For instance, a proteasome molecule, the subunit PSMA7(a4) has 
been shown to directly bind to MAVS and reduce its ability to translocate downstream 
IFN signals. This regulation operates through a MAVS proteasomal degradation-
dependent mechanism (Jia et al., 2009). The autophagy conjugate Atg5-Atg12 has 
been shown to regulate RLR signalling via direct interactions with both CARD domains 
of RIG-I and MAVS to limit the downstream IFN production (Jounai et al., 2007). SIKE 
(Suppressor of IKK-epsilon) is a physiological suppressor of TBK1 and IKKε that keeps 
these kinase proteins sequestered in inactive complexes to prevent non intentioned 
activation by any RLR (Huang et al., 2005).   
The specific regulation of MDA5 through protein interactions is less understood. 
However, MDA5 regulation has been described to occur via DAK (dihydroacetone 
kinase), in which, the overexpression of this molecule leads to diminished IFN 
responses to MDA5 agonists. Besides, DAK was found to interact with MDA5 but not 
with RIG-I, suggesting that the mechanism for the activation acts in order to prevent 
MDA5 activation and its interaction with MAVS. There’s still a requirement for further 
comparison studies between the regulatory mechanisms of RIG-I and MDA5, with the 
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purpose of defining specific regulatory processes that take place via protein 
interactions (Diao et al., 2007). 
Recent studies identified unique roles for some members of the caspase family in 
the regulation of RLR signalling (Kim and Yoo, 2008; Takahashi et al., 2006; Wang et 
al., 2010). This family of proteins perform in the activation of apoptotic cascades 
[reviewed at (Fan et al., 2005)] as well as targeting the inflammasome activation 
through processing and liberation of IL-1β, IL-18 and IL-33 [reviewed at (Kanneganti, 
2010)]. 
Caspase 1, whose functions as inflammatory caspase and whose expression is 
activated during viral infections, was demonstrated to negatively regulate RIG-I 
signalling by promoting RIG-I secretion, therefore controlling its intracellular levels (Kim 
and Yoo, 2008). It is yet not clear how RIG-I is secreted but, since RIG-I interacts with 
caspase 1 and it was found in supernatant together with caspase 1, an hypothesis 
arises, stating that RIG-I secretion involves the inflammasome complex. However its 
physiological significance has not yet been clarified (Kim and Yoo, 2008). 
Caspase 8 has shown to associate with MAVS signalosome  via interactions with 
FADD, RIP1 and MAVS, after dsRNA stimulation (Rajput et al., 2011; Takahashi et al., 
2006). Caspase 8 can function by supressing RLR signalling via two distinct 
mechanisms. First, caspase 8 promotes direct depletion of RIG-I through a mechanism 
dependent on its ability to bind to FADD, and independent of its cleaving ability. 
Second, caspase 8 cleaves RIP1 at signalosome complex, leading to the loss of IFN 
induction. These roles of caspase 8 are thought to act in the negative regulation and 
terminate RLR response in later stages after the initial RLR triggering during an acute 
viral infection. However, a further understanding of the RIP1 cleavage mechanism is 
needed for a better comprehension of how this process regulates MAVS signalosome 
and RLR functions (Rajput et al., 2011). 
Caspase 12 has also been identified as a negative regulator of RLR signalling 
(Wang et al., 2010). Using a West Nile virus (WNV) infection model, caspase12-/- mice 
showed higher mortality rates to viral infection. Besides, knockout mice cells failed to 
mediate TRIM25 ubiquitination of RIG-I, and this correlates with the decrease in IFN 
responses and lack of protection against WNV. The exact mechanism by which 
caspase 12 regulate TRIM25 has yet to be described, requiring further analysis. 
Additionally, since only a small percentage of the human population expresses 
caspase 12, its role in RLR regulation remains debatable. However, this study 
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identified the potential cross-talk between the RLR and caspase signalling pathways as 
regulatory features that govern the antiviral immune response (Wang et al., 2010). 
Since the CARD-CARD interactions play an important role in both, RLR and caspase 
pathways, it is likely that more regulatory interactions will be identified in a near future.  
Proteins localized at mitochondria are logical candidates for MAVS regulation. The 
first mitochondrial protein identified as a negative regulator of MAVS was NLRX1 
(nucleotide-binding oligomerization domain, leucine rich repeat containing X1) (Moore 
et al., 2008). NLRXs are members of the NOD-like cytosolic receptors family of pattern 
recognition receptors, which initially were thought to be independent of RLR signalling. 
This study confirmed the putative localization of NLRX1 at the outer mitochondrial 
membrane and went on by showing that NLRX1 interacts with MAVS through its CARD 
domain, disrupting upstream interactions with MAVS interacting partners (Moore et al., 
2008). This data was corroborated in NLRX1-/- MEFs: IFN-β production was enhanced 
in NLRX1 knockout MEFs infected with a variety of viruses known to induce RIG-I 
(Allen et al., 2011). Interestingly, NLRX1-deficient cells exhibit RIG-I–MAVS 
association, even in the absence of viral infection. This constitutive association 
between RIG-I and MAVS in the absence of NLRX1 may explain the increase of IFN-β 
response to a viral infection that uses RIG-I but not with viruses that require MDA5 
(e.g. encephalomyocarditis virus) (Allen et al., 2011). There are, however, contradicting 
results, since two studies using NLRX1 knockout MEFs, independently showed no 
potentiation of IFN induction or IRF3 phosphorylation in response to poly I:C or Sendai 
virus (SeV), in comparison with wild-type MEFs under poly I:C infection (Rebsamen et 
al., 2011; Soares et al., 2012). Another study reported that inhibition of the RLR 
signalling pathway may be an artefact of inhibition of the luciferase activity, which is 
quite relevant, since many of the previously mentioned studies used luciferase based 
assays to measure RLR signalling (Ling et al., 2012). Like the LGP2 inhibition of MAVS 
activity, NLRX1 have led to contradicting results. It is plausible that NLRX1 possesses 
several regulatory roles, depending on which ones are advantageous for the cell. 
Further studies are required to reconcile these findings and clarify the exact role of 
NLRX1 in MAVS signalling.  
STING, also known as MITA, MPYS or ERIS, was originally identified as a RIG-I 
signalling regulator, owing its ability of direct binding to RIG-I, MAVS and TBK1 to its 
knockout phenotype (Ishikawa and Barber, 2008; Jin et al., 2011; Sun et al., 2009; 
Zhong et al., 2008). Overexpression of active fragments of RIG-I failed to induce IFN in 
STING-deficient MEFs. Besides, VSV infection in STING-deficient mice resulted in 
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significantly reduced survival rates and lower IFN serum levels, comparatively to 
control mice (Ishikawa and Barber, 2008). Thus, STING has been found to play an 
indisputable role in IFN response to cytosolic DNA from viruses or synthetic agonists. 
Along with the mitochondria-resident proteins, those who relocate to mitochondria 
during a given viral infection also represent a cluster of MAVS regulators. Complement 
protein gC1qR (receptor for globular head domain of complement component C1q) 
was investigated for its role in antiviral signalling, due to reports that it is involved in 
cytomegalovirus and rubella infections (Xu et al., 2009). gC1qR localizes at 
mitochondria, nucleus, cytoplasm and cell surface. Interestingly, it has been 
demonstrated that gC1qR is recruited to mitochondria upon viral infection or poly I:C 
stimulation. Overexpression of gC1qR inhibits antiviral signalling activated by virus, 
poly I:C or exogenous RLRs. In addition, gC1qR and MAVS interact weakly in non-
infected cells; this interaction was strongly enhanced upon viral infection. gC1qR 
knockdown, mediated by RNAi, resulted in an increased antiviral response to 
exogenous RIG-I or VSV infection (Xu et al., 2009). This study revealed a role for this 
complement receptor, which is known to act in several branches of innate immunity, in 
the regulation of RLR signalling through its interaction with MAVS.  
 
2.3.2 – Regulation by posttranslational modification events 
The posttranslational control of proteins is a common mean by which cells regulate 
a diversity of pathways and processes. Thus, it is not surprising that posttranslational 
modifications of RLR signalling pathway components are a key aspect in the cell 
antiviral signalling regulation. Specific modifications of RLRs and their co-factors 
impose regulation of signalling of the immune defences in a variety of levels, ranging 
from RLR activity to the assembly and function of MAVS signalosome. 
Posttranslational modifications such as ubiquitination or deubiquitination are a major 
point of the RLR regulation. RNF135 protein (RING finger protein leading to RIG-I 
activation or Riplet) is an ubiquitin-ligase that interacts with RIG-I but not with MDA5 
(Oshiumi et al., 2009, 2010). It is reported to mediate the conjugation of K63-linked 
polyubiquitin chains to RIG-I at its C-terminal domain, as well as in its repressor 
domain, and it is crucial to the virus-induced IFN signalling (Oshiumi et al., 2009). 
RNF135-deficient mice weren’t able to produce IFNs or cytokines during a RNA virus 
infection, and subsequently, those mice were more susceptible to viral infection than 
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wild-type mice (Oshiumi et al., 2010). TRIM25 also mediates K63-linked 
polyubiquitination of RIG-I at aa. K172 upon viral infection (Gack et al., 2007). This 
modification is thought to stabilize RIG-I and MAVS interactions to induce the activation 
of IFN production (Gack et al., 2007). However, free K63-polyubiquitin chains are 
also able to induce RIG-I activation in an in vitro reconstitution of the RIG-I pathway, 
suggesting that it is the actual polyubiquitin chain binding at K172 and not the ubiquitin-
induced change that leads to RIG-I activation (Zeng et al., 2010). This data suggested 
that K63-polyubiquitin chains act as the second ligand to increase activation of RIG-I 
signalling (Zeng et al., 2010).  
RIG-I signalling is also subject of regulation by the ubiquitin editing protein A20 (Lin 
et al., 2006). A20 has both ubiquitin-ligase and deubiquitinase activities; however, only 
the ubiquitin-ligase activity, linked to its C-terminal, is important for the RLR signalling 
regulation. Overexpression of A20 inhibits RIG-I-dependent activation of IRF3 and NF-
kB, while its depletion increased virus-induced signalling, suggesting its role as a 
negative regulator of RLR pathway (Lin et al., 2006). Additionally, TRAF3, a K63-linked 
ubiquitin-ligase and essential regulator of IRF3 activation induced by viral infection, 
was found to regulate IFN but not inflammatory cytokine production during viral 
infection (Häcker et al., 2006). TRAF3 binds to TIM (TRAF-interacting motif), which is 
found at the proline-rich region of MAVS and facilitates the IKKε recruitment to the 
MAVS signalosome (Saha et al., 2006). TRAF3 activity in RLR signalling is further 
regulated by the E3 ubiquitin-ligase Triad3A (Nakhaei et al., 2009), the OTUB1, 
OTUB2 (Li et al., 2010) and DUBA (Kayagaki et al., 2007) deubiquitinases, and the 
interferon-stimulated gene FLN29 (Sanada et al., 2008), alongside with the stability of 
the interactions between IKKε and MAVS (Paz et al., 2009) and by the PLK1 (Polo-like 
kinase 1) – MAVS interactions (Vitour et al., 2009).  
RNF125 is another ubiquitin-ligase that cooperates with E2 ubiquitin-ligase HbcH5 
to conjugate K48-linked ubiquitin to RIG-I, MDA5 and MAVS in order to mediate 
proteasomal degradation (Arimoto et al., 2007). RNF125 is an ISG itself, whose 
expression is induced after viral infection and its action is part of a negative feedback 
loop to prevent an excessive IFN production. RNF125 activity is supressed by UbcH8 – 
the same ubiquitin-ligase responsible for the conjugation of ISG15 to target proteins 
during a viral infection (Arimoto et al., 2008). Based on cumulative evidence, it was 
proposed that the interaction of ISG15 with UbcH8, simultaneously with virus-induced 
ISG15 expression, dissociates from its interaction with RNF125. This action will then 
facilitate the ubiquitin conjugation by RNF125 at RIG-I and other molecules to inhibit 
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RLR signalling and IFN expression (Arimoto et al., 2008). Consistent with this model, 
basal expression of RIG-I is higher in Ube1-deficient cells that fail in their ability to 
conjugate ISG15, comparatively to wild-type cells, providing RIG-I amounts that 
facilitate a robust RLR signalling (Arimoto et al., 2008). In addition, the tumour 
suppressor CYLD is a deubiquitinase that interacts with both RIG-I and MAVS (Zhang 
et al., 2008). It was previously shown to be essential to prevent aberrant activation of 
IKKε and TBK1 (Zhang et al., 2008). Consistent with this finding, CYLD expression-
deficient cells signal a constitutive activation and exhibit an hyper-induction of IFN 
during viral infection (Zhang et al., 2008). Besides, a recent study suggests that CYLD 
operates in the removal of polyubiquitin chains from RIG-I and TBK1 to inhibit IRF3 
signalling and further IFN production within the MAVS signalosome (Friedman et al., 
2008). Taken together, these studies define a critical role for reversible ubiquitination of 
RLRs and co-factors at the RLR signalling pathway during an immune response to a 
viral infection.  
RLR signalling pathway is also regulated by additional posttranslational 
modifications, including phosphorylation, acetylation and SUMOylation. Aside from the 
previously described modification events that govern ubiquitination, further 
posttranslational modifications of RIG-I serve as means of prevention of its premature 
activation in the absence of PAMPs, and represent another level of regulation of the 
RLR activation. For instance, casein kinase II phosphorylates RIG-I at its resting state 
at threonine 770, serine 854 and 855 (Sun et al., 2011). Mutations at these sites, 
chemical inhibition or casein kinase II depletion turn RIG-I into a constitutive active 
state, resulting on an augmented IFN induction. By contrast, treatment of cells with 
phosphatase inhibitor supresses RLR-dependent signalling, suggesting that RIG-I 
phosphorylation is required to maintain the auto-regulation of its repressor domain (Sun 
et al., 2011). RIG-I was additionally identified to be acetylated in its K858 and K909 
residues; however, it remains undetermined how acetylation of lysine regulates RIG-I 
signalling activity (Choudhary et al., 2009).  
Downstream components of RLR signalling are also regulated by posttranslational 
modifications. Of note, the virus-induced activation of TLR and RLR pathways are 
known to lead to SUMOylation of IRF3 and IRF7 at their K152 and K406, respectively 
(Kubota et al., 2008). Mutants of these factors that cannot support SUMO modification 
exhibit an increased IFN induction, suggesting that the SUMO modification of IRF3 and 
IRF7 is a negative regulation mechanism (Kubota et al., 2008). 
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The specific posttranslational modifications of MAVS were already introduced in the 
previous chapter as well as the present one, but further discussion is required in order 
to approach some novel regulatory mechanisms of RLR signalling. 
 
Figure 19 – Mechanisms of MAVS regulation.  
MAVS can be regulated by host cell factors that inhibit MAVS signalling by direct protein-protein 
interactions, by altering mitochondrial properties or dynamics, or by post-translational 
modifications. PRR – proline-rich region; Ub – ubiquitination; P – phosphorylation. Positive 
regulators of MAVS signalling are shown in green text and negative regulators of MAVS 
signalling are shown in red text. Note that LGP2 is shown in both red and green given the 
confliting results on its role in the regulation of RLR signalling. (Jacobs and Coyne, 2013) 
 
 
PCBP2 acts as negative regulator of MAVS, mediating its ubiquitination and 
proteasomal degradation (Fuping You et al., 2009). PCBP2 is involved in DNA and 
RNA binding with several purposes within the cell, including mRNA stability and 
regulation of protein translation (Makeyev and Liebhaber, 2002). Overexpression of 
PCBP2 results in the suppression of IFN-β induction mediated by MAVS but has no 
effect in TBK1 – IRF3 signalling. PCBP2 was highly induced under interferon treatment 
and viral infection, and the interaction between endogenous PCBP2 and endogenous 
MAVS was induced by SeV infection. Subcellular localization studies showed that 
PCBP2 localizes primarily at the nucleus but re-localizes to the cytoplasm, where it co-
localizes with MAVS upon viral infection or MAVS overexpression. Despite not having 
any ubiquitin kinase activity by itself, PCBP2 overexpression induces MAVS 
proteasomal degradation. Through mutational analysis of MAVS, the authors showed 
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that ubiquitination of two specific residues of lysine lead to MAVS degradation and 
revealed that polyubiquitination levels of MAVS where higher in the presence of 
overexpressed PCBP2. Given that PCBP2 isn’t an ubiquitination enzyme, the authors 
proposed that PCBP2 can act as a scaffold, binding MAVS to an E3 ubiquitin-ligase 
(Fuping You et al., 2009). 
Tracing for known E3 ubiquitin-ligases for a potential candidate that mediates MAVS 
degradation and binds to PCBP2, the authors found the E3 ubiquitin-ligase AIP4, a 
Nedd4-like E3 ubiquitin-ligase (Fuping You et al., 2009). Overexpression of AIP4 
partially interrupted IFN-β signalling and induced MAVS degradation, in an ubiquitin-
ligase activity-dependent manner. Despite being demonstrated that AIP4 interacts with 
MAVS, this interaction requires PCBP2, which suggests that PCBP2 actually functions 
as a scaffold to facilitate the AIP4-dependent MAVS degradation. This was confirmed 
using in vitro ubiquitination assays, which showed that PCBP2 expression greatly 
increases AIP4-mediated ubiquitination and, consequently, MAVS degradation. At last, 
IFN-β signalling was increased in mice Itch-/- MEFs (Itch is the mice AIP4 homolog), 
further connecting this E3 ligase to MAVS signalling. Collectively, this study proved that 
PCBP2 acts as an adaptor for AIP4-mediated MAVS ubiquitination, and subsequent 
proteasomal degradation of MAVS in order to negatively regulate the RLR pathway, 
lighting up a novel mechanism for RLR pathway regulation (Fuping You et al., 2009). A 
later study by the same group has demonstrated that PCBP1 is also involved in MAVS 
negative regulation, using a similar mechanism (Zhou et al., 2012). However, and 
unlike PCBP2, PCBP1 doesn’t induce type I IFNs, leading the authors to conclude that 
PCBP1 acts as a “housekeeper” for MAVS levels and is not exactly a negative 
feedback inhibitor (Zhou et al., 2012).   
Besides acting in RIG-I specific regulation, TRIM25-dependent ubiquitination also 
plays a role in regulation of MAVS through a negative feedback mechanism different 
than other ubiquitin-ligases (Castanier et al., 2012). TRIM25 overexpression enhanced 
MAVS ubiquitination and degradation, and catalysed the addition of ubiquitin in two 
specific residues of MAVS (K7 and K10). Functional studies revealed that exogenous 
TRIM25 increases IFN-β promoter activity, stimulated by high molecular weight poly I:C 
(a known MDA5 agonist used to avoid experimental complications related with TRIM25 
modification of RIG-I) and, conversely, TRIM25 depletion lead to attenuation of IFN-β 
promoter activity, due to a diminished ubiquitination and degradation of MAVS. Based 
in these observations, the authors proposed that, under RLR activation, MAVS 
signalosome was assembled at the mitochondria, and only under TRIM25-mediated 
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ubiquitination and proteasomal degradation MAVS can be released and translocate to 
the cytosol to phosphorylate IRF3 and subsequently induce IFN-β production. While 
this presents as a tempting hypothesis, it remains unverified if the degradation 
elimination of MAVS (perhaps through mutational analysis of the MAVS ubiquitinated 
residues) maintains the same effect in the IRF3-mediated IFN-β induction (Castanier et 
al., 2012). 
Ndfip1 has also been classified as a negative regulator of MAVS at mitochondria via 
an increase in ubiquitination and proteasomal degradation (Wang, Tong, and Ye, 
2012). In light of cumulative evidence establishing connections between E3 ubiquitin-
ligase activity with MAVS regulation, Ndfip1 is a logical candidate, given its role in the 
enhancement of protein ubiquitination through interactions with the E3 ubiquitin-ligase 
family known as Nedd3 ubiquitin-ligases. Ndfip1 inhibited MAVS-mediated signalling in 
a proteasome-dependent manner. Since these results pointed to proteasomal 
degradation mediated by ubiquitination as the regulatory mechanism of MAVS, the 
authors performed a screening of other four members of Nedd4 E3 ubiquitin-ligase 
family, for their ability to induce MAVS degradation, but not RIG-I or TBK1, in the 
presence of Ndfip1. Nedd4 E3 ubiquitin-ligase Smurf1 led to MAVS degradation but 
not RIG-I/TBK1, in the presence of Ndfip1. Smurf1 and MAVS interaction was 
enhanced in the presence of Ndfip1, as well as the Smurf1-mediated MAVS 
ubiquitination, indicating that Ndfip1, probably, serves as an adaptor for the recruitment 
of Smurf1 to MAVS. This study described a regulatory mechanism similar to PCBP2 
and AIP4 and provides another example of the complexity of ubiquitination in MAVS 
signalling regulation (Wang, Tong, and Ye, 2012). 
TSPAN6 (tetraspanin protein 6) was recently described for its role in RLR-mediated 
MAVS signalling (Wang, Tong, Omoregie, et al., 2012). TSPAN6 is a member of the 
membrane-embedded tetraspanin protein family that have been showing several roles 
within the cell, including a variety of roles in host immunity [reviewed at (Hemler, 
2005)]. Interestingly, TSPAN6 does not promote direct MAVS ubiquitination but it is 
ubiquitinated itself, in order to promote its association with MAVS and to disrupt MAVS 
signalosome at mitochondria. Overexpression of TSPAN6 resulted in a reduction of 
exogenous MAVS-induced signalling and showed interaction with MAVS. The authors 
proposed that TSPAN6 ubiquitination, in the presence of viral infection, promotes its 
recruitment to the mitochondria, where it interacts with MAVS, disrupting the assembly 
of MAVS signalosome, thus inhibiting antiviral signalling. The responsible enzymes for 
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TSPAN6 ubiquitination, in the context of RLR activation, are yet to be determined 
(Wang, Tong, Omoregie, et al., 2012). 
Just like ubiquitination, phosphorylation represents a posttranslational mechanism 
of protein regulation of a variety of cellular processes such as the RLR signalling. A 
recent report revealed that UBNX1 (ubiquitin regulatory X domain-containing protein) 
negatively regulates MAVS by binding and blocking its interaction with TRAF3/TRAF6 
at their binding site at MAVS C-terminal, supporting even further the importance of this 
region in MAVS mediated signalling (Wang et al., 2013). More recently, tyrosine kinase 
c-Abl was identified as MAVS interacting partner, acting as its positive regulator by 
direct interaction and phosphorylation (Song et al., 2010). c-Abl is a nuclear and 
cytoplasmic Src-like non-receptor protein tyrosine kinase known to play different roles 
within the cell [reviewed at (Backert et al., 2008; Koleske, 2006)]. MAVS–c-Abl 
interaction has shown to require both transmembrane domain and CARD domain of 
MAVS, probably suggesting that MAVS mitochondrial localization is fundamental for 
this interaction. c-Abl depletion results in an abrogated MAVS signalling and 
pharmacological inhibition of c-Abl disrupts IFN-β production in response to VSV 
infection. Tyrosine phosphorylation of MAVS was increased by c-Abl expression but 
not by a c-Abl mutant lacking its kinase activity ability (Song et al., 2010). In a later 
report, tyrosine-scanning mutational analysis revealed that inducible phosphorylation 
at MAVS Tyr9 residue is involved in the recruitment of TRAF3/TRAF6 to propagate 
MAVS-mediated RLR signalling (Wen et al., 2012). If c-Abl is involved in Tyr9 
phosphorylation of MAVS is yet to be determined and might represent an interesting 
follow-up for these two studies.  
 
 2.3.3 – Organelle dynamics as regulatory mechanisms of RLR signalling 
pathway 
All three receptors of RLR family are cytosolic proteins and haven’t been associated 
to any subcellular structure in steady-state. However, several signalling components 
downstream of these receptors are membrane proteins, whose functional domains 
project to the cytosol from the surface of the respective organelles. More important, the 
correct localization of such proteins is a requirement for their biological activity, and the 
physical proprieties of the organelles where they reside may play a role in the 
regulation of their activities. The best characterized example in this context is the 
adaptor protein MAVS.  
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Initial evidence for the role of mitochondrial dynamics in MAVS signalling came from 
studies demonstrating that SeV-infected cells or poly I:C transfection resulted in 
mitochondrial elongation/fusion, leading the authors to conclude that activation of the 
RLR signalling pathway results in physical alterations in mitochondria themselves 
(Castanier et al., 2010). In fact, the same study also demonstrated that phosphorylation 
of IRF3 was delayed in cells with fragmented mitochondria and that RLR signalling was 
attenuated by mitochondrial fragmentation and increased by mitochondrial fusion. 
Immunoprecipitation experiments revealed that MAVS interacts with MFN1 (mitofusin 
1), a protein responsible for the regulation of mitochondrial fusion events, suggesting a 
possible role of this interaction in the mitochondrial dynamics regulation that 
accompanies antiviral signalling (Castanier et al., 2010). Interestingly, a later report 
about MAVS – MFN1 interaction showed that MFN1 acts as a positive regulator of 
MAVS-mediated antiviral signalling by redistributing MAVS to speckle-like aggregates, 
observed after RLR signalling activation. This can explain why MFN1 and mitochondrial 
fusion seem to be important in RLR signalling, given that mitochondria may facilitate 
MAVS aggregation (Onoguchi et al., 2010). Others have investigated the role of MFNs 
in MAVS signalling using MFN1/MFN2-deficient MEFs; these cells were unable to 
undergo mitochondrial fusion and presented a compromised ability to produce IFN-β 
and IL-6, in response to a given viral infection (Koshiba et al., 2011). In line with these 
results, it is likely that the role of MFNs in the innate immune signalling is versatile. Not 
only MFN1 and MFN2 can directly interact with MAVS to exert a regulatory role, but 
their activities in mitochondrial dynamics appear to be important in MAVS functions. 
This is in accordance with previous studies, where MAVS activation required auto-
association in higher order oligomers and the formation of large prion-like aggregates 
to induce powerful antiviral signal propagation (Hou et al., 2011; Tang and Wang, 
2009). Recently, prion-like aggregates containing MAVS were reported to be 
responsible for downstream signal propagation by binding to TRAF2, TRAF5 and 
TRAF6 in an ubiquitin-dependent manner. This study also provides evidence that 
TRAF2 and TRAF5 act redundantly with TRAF6 to activate IRF3 (Liu et al., 2013). 
Additionally, MFN1 and MFN2-deficient cells exhibit a dissipated mitochondrial 
membrane potential, suggesting that mitochondrial membrane potential may be 
important in RLR antiviral response (Koshiba et al., 2011). In wild-type MEFs, the 
dissipation of such potential caused a deficiency in MAVS-mediated antiviral response. 
These results demonstrated that the ability of mitochondria to fuse correctly and to 
maintain an appropriate membrane potential are crucial events of MAVS signalling 
(Koshiba et al., 2011).  
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Figure 20 – Mitochondrial dynamics regulate MAVS signalling.  
a) During infection, RIG-I and MAVS-enriched mitochondria are recruited around centres of viral 
replication to promote MAVS signalling. This occurs as mitofusin 1 (MFN1) and MFN2 induce 
fusion of the mitochondrial network, which also serves to increase MAVS interactions with 
downstream signalling molecules. Mitochondrial MFN1 and MFN2 also interact with 
endoplasmic reticulum-localized MFN2, which promotes interactions between MAVS and 
STING at mitochondrial-associated membranes (MAMs). b) Fragmentation of the mitochondrial 
network – which is induced by viral infection, mitofusin deficiency or overexpression of fission-
promoting molecules – results in decreased mitochondrial membrane potential and blocks 
interactions between MAVS and signalling molecules such as STING. This leads to reduced 
signalling by NF-kB, IRF3 and IRF7. (West et al., 2011) 
 
 
Besides regulating mitochondrial fusion, MFN2 is also important in the tethering 
between mitochondria and the endoplasmic reticulum (ER) at MAMs (mitochondrial 
associated membranes) (Horner et al., 2011). MAMs are a subcellular domain 
emerging in MAVS signalling. For instance, infected cells exhibit increased numbers of 
ER-elongated mitochondria contacts, in comparison with non-infected cells, suggesting 
that these contacts are augmented under mitochondrial fusion and elongation, induced 
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by infection. This is particularly important, given that the MAVS population that resides 
in MAMs is quite important for antiviral signalling (Horner et al., 2011). A recent study 
described a role for FAK (focal adhesion kinase) in positive regulation of MAVS-
mediated antiviral signalling (Bozym et al., 2012). FAK is a tyrosine kinase protein that 
localizes in contact points between extracellular matrix and the intracellular 
cytoskeleton, known as focal adhesions. This study demonstrated that FAK-knockdown 
MEFs were highly susceptible to viral RNA but did not reveal susceptibility to DNA virus 
infections. FAK-knockdown MEFs were attenuated in IFN-β and NF-kB signalling in 
response to poly I:C. Surprisingly, co-immunoprecipitation and immunofluorescence 
microscopy assays demonstrated that FAK re-localizes from focal adhesions to the 
mitochondrial membrane, where it interacts with MAVS, in a viral infection-dependent 
manner.  Despite of the exact role of FAK in MAVS signalling remain undetermined, 
MAVS and mitochondria distribution is quite abnormal in FAK-deficient cells, 
suggesting a potential role in mitochondrial dynamics regulation, required to facilitate 
MAVS downstream signalling (Bozym et al., 2012).  
As previously mentioned in this chapter, STING, is an ER-linked protein that 
modulates MAVS signalling, and, in addition to its localization at the ER outer 
membrane in four transmembrane domains, STING is also expressed at the 
mitochondrial outer membrane (Zhong et al., 2008). Following RIG-I activation, STING 
interacts with MAVS and facilitates TBK1 recruitment and subsequent IRF3 
phosphorylation (Zhong et al., 2008). STING is able to bind itself to RIG-I but not to 
MDA5 and does not respond to poly I:C activation, indicating that STING acts strictly 
downstream of RIG-I (Ishikawa and Barber, 2008). Interestingly, STING was shown to 
interact with components of the translocon-associated protein complex (TRAPβ) and 
SEC61β translocon, essential interactions for a proper STING signalling (Ishikawa and 
Barber, 2008). Taken together, these observations suggest that special regulation of 
STING at ER and mitochondria is essential for the RIG-I–dependent antiviral response, 
despite the mitochondrial and ER STING proportions remain difficult to determine, due 
to the close interaction between these two organelles. Cumulative evidences underline 
the importance of the physical platform – denominated Mitochondria associated 
membranes (MAMs) – that connect ER to mitochondria (Horner et al., 2011; Pinton et 
al., 2011). Disruption of MAMs has been linked to imbalances in calcium signalling, 
cellular stress and apoptosis deregulation (Pinton et al., 2011). 
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Regulation of ROS (reactive oxygen species) has also been reported to have a role 
in positive regulation of RLR signalling from mitochondria. Examining the mechanism 
for this phenomenon, Zhao et al. described COX5B (cytochrome C oxidase 5B) as a 
novel MAVS interacting partner, responsible for ROS repression and RLR signalling (Y. 
Zhao et al., 2012). COX5B is a mitochondrial protein and a member of the oxidase 
cytochrome c – known to catalyse the last step of the electron transport chain. 
Overexpression of COX5B diminished MAVS-mediated signalling without any effect in 
TLR or TNF-α mediated signals, suggesting an effect specific to the RLR pathway, 
while cells with COX5B depletion exhibit augmented antiviral signalling. Interestingly, in 
addition to its roles in ATP production, COX5B has also been shown to be involved in 
negative regulation of ROS production. In order to investigate the possible role of this 
pathway in MAVS regulation, the authors used two components known to alter ROS 
levels and found that an increase in ROS results in an increased MAVS signalling and 
diminished levels of ROS have the opposite effect. Additionally, cells expressing 
exogenous MAVS produced higher levels of ROS, which was disrupted by introduction 
of exogenous COX5B (Y. Zhao et al., 2012).  
The autophagosome is another organelle involved in the regulation of the innate 
immune response. As mentioned before, the Atg5-Atg12 conjugate (essential for the 
formation of the autophagosome) was shown to negatively regulate RIG-I pathway by 
direct interactions with RIG-I and MAVS (Jounai et al., 2007). Additionally, IFN 
production was increased in response to poly I:C treatment in Atg5 knockout, 
autophagy-deficient cells, that are characterized for mitochondrial accumulation (Tal et 
al., 2009). This phenotype can be explained by the fact that autophagosomes are 
responsible for the removal of several types of old or damaged organelles, including 
mitochondria. Mitochondria accumulation has two effects: it leads to an increase of 
MAVS, what partially explains the increase in IFN production; and the accumulation of 
damaged mitochondria induces an increase in mitochondrial reactive oxygen species 
(mROS). The same study demonstrated that mROS can stimulate RLRs, ultimately 
leading to IFN induction (Tal et al., 2009).  
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2.4 – MAVS downstream signaling cascade: the antiviral effector response – 
type I IFN induction and ISG production  
As previously stated at chapter 2.1, IRF3/IRF7 and NF-kB, once properly activated, 
translocate to the nucleus where they interact with the IFN-β promoter in a highly 
coordinated manner. The final steps from that point on, ending with the actual 
production of ISGs will now be explored in greater detail. Since IFN-α induction also 
depends upon IRFs actions, it will also be addressed in this chapter.  
 
2.4.1 – IRF3 and IRF7 – the antiviral IRFs 
The specificity of type I IFN induction is achieved by members of the transcription 
factor family, the Interferon Regulatory Factors (IRFs) (Honda et al., 2006; Nguyen et 
al., 1997). At total, nine interferon regulatory factors were identified: IRF-1, IRF-2, IRF-
3, IRF-4/Pip/ICSAT, IRF-5, IRF-6, IRF-7, IRF-8/ICSBP and IRF-9/ISGF3g/p48 (Hiscott, 
2007a; Nguyen et al., 1997). Each member shares extensive homology at their N-
terminus DNA binding domain (DBD), characterized by five tryptophan repetition 
elements in their first 150 amino acids (Nguyen et al., 1997). The IRF DNA-binding 
domain mediates the specific binding to IFN-stimulated regulatory elements (ISREs) in 
IFN stimulated genes.(Honda et al., 2006; Nguyen et al., 1997)  
In addition to their role in immunity, IRFs are also involved in the regulation of the 
cell cycle, apoptosis and tumour suppression (see Figure 13) (Honda et al., 2006). 
Each IRF contains an unique C-terminal, named IRF-association domain (IAD) (Honda 
et al., 2006; Nguyen et al., 1997). The particular function of a certain IRF its accounted 
by the IAD ability to interact with other members of the IRF family, through its 
transactivation potential, interaction with other factors, and the specific expression of 
IRFs in a given cell line (Hiscott, 2007a; Nguyen et al., 1997). 
 
 
 
 
 
 
 
Universidade de Aveiro                                             Mitochondria and Peroxisomes: role within  
cellular antiviral defense 
 
  
Mariana Guedes   79 
 
 
Table 2 - The IRF family members and their immune actions.  
(Richez et al., 2010) 
 
 
 
The search for IRFs that might activate IFN-α and IFN-β gene promoters led to the 
identification of IRF3 and IRF7, the so called “antiviral IRFs” (Au et al., 1995). The 
identification of these IRFs and their role in the transcriptional activation of type I IFN 
genes had a great impact in the comprehension of the molecular mechanisms of 
antiviral response induced by pathogens (Hemmi et al., 2004). It became quite obvious 
that, in spite of the recognition of pathogens being mediated by distinct cellular 
receptors and signalling pathways, all of them lead to IRF3/IRF7 activation, a critical 
step for the transcriptional activation of type I INF genes (Kishore et al., 2002; Paun, A; 
Pitha, 2007). 
The IRF3 member was first identified in a database search for IRF1 and IRF2 
homologues (Au et al., 1995). The IRF3 gene (single gene copy at chromosome 
19q13.3-13.4) encodes a 427 aa. phosphoprotein of 55kDa, which is constitutively 
expressed throughout a majority of tissues and cell lines, sharing most homology with 
IRF-8 and IRF-9 (Bellingham et al., 1998; Lin et al., 1999; Mamane et al., 1999). The 
transcriptional activity of IRF3 is controlled by viruses, induced by dsRNA, 
phosphorylation events at Ser. 385 and Ser.386 at the C-terminal, as well as 
phosphorylation at a serine/threonine cluster between aa. 396 to 405 – mediated by 
IKK-related kinases (TBK1 and IKKε) (Lin et al., 1998; Sharma et al., 2003; Yoneyama 
et al., 1998). A model for IRF3 activation was proposed, where C-terminus 
phosphorylation induces a conformational change in IRF3 that allows homo and 
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heterodimerization, dependent of association with CREB-binding protein/p300 
(CBP/p300) (Sharma et al., 2003; Weaver et al., 1998). The activated IRF3 
translocates to the nucleus, while its association with CBP/p300 retains IRF3 inside the 
nucleus, facilitating IFN-β transcription (Weaver et al., 1998). The IRF3 
phosphorylation, ultimately leads to its degradation via ubiquitin-proteasome (Hiscott, 
2007b; Lin et al., 1998). 
The IRF7 member was first described by its binding and repression functions at the 
Qp promoter of the Epstein Barr virus (EBV), which regulates the EBV antigen 1 
(EBVA1) – that contains a ISRE-like element – but its relevance in IFN-α gene 
regulation was rapidly recognized (Au, 1998; Marié et al., 1998; Sato, Hata, et al., 
1998). Unlike IRF3, IRF7 is not constitutively expressed (except for B cells and 
dendritic cells); instead, it is induced by viral infection, IFNs and it presents an half-life 
of only 30 minutes, which can represent a mechanism of transient induction of IFNs 
(Lin et al., 2000; Marié et al., 1998). Phosphorylation of serine residues acts as a 
catalyser for IRF7 activation and it is critical for its translocation to the nucleus; 
particularly, the C-terminus region between aa. 471-487 has been identified as the 
target for phosphorylation (Caillaud and Hovanessian, 2005). 
Re-examining the RIG-I signaling pathway in Figure 13, it is clear that IRF3/IRF7 are 
the substrates of TBK-1 and IKKε kinases; both directly phosphorylate IRF3 and IRF7 
at identical key residues at their respective C-terminals (Perry et al., 2004; Tenoever et 
al., 2007). The alignment of the primary sequence of the C-terminal domains of IRF3 
and IRF7 revealed an extensive consensus motif SxSxxxS that appears to be the 
target of IKKε and TBK-1 (Hiscott, 2007a). Interestingly, RNAi treatment directly 
against IKKε and TBK1 reduces IRF3 phosphorylation and expression of IRF-
dependent genes upon VSV infection in human cells (Benjamin et al., 2004). Further 
analysis of TBK1 -/- and IKKε -/- mice demonstrated that TBK1 is mainly involved in 
downstream signaling to IRF3 and IRF7 phosphorylation and development of an 
antiviral response, while recent experiments suggest that IKKε selectively regulates a 
subset of antiviral IFN genes during viral infection: IKKε-deficient mice produced 
normal levels of IFN-β but were hyper-susceptible to viral infection due to a defect in 
the IFN signaling pathway (Matsui et al., 2006; McWhirter et al., 2004). Specifically, a 
subset of IFN-stimulated genes wasn’t activated in the absence of IKKε, once ISGF3 
(Interferon-Stimulated Gene Factor 3) failed to bind to the promoters of the affected 
genes, thus confirming the requirement of the kinase activity of IKKε to regulate, at 
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least in part, the downstream transcription machinery necessary for the direct antiviral 
response (Tenoever et al., 2007).  
 
2.4.2 – NF-kB & its antiviral role 
The Rel/NF-kB family is the most studied collection of transcription factors. NF-kB 
proteins play their most evolutionarily conserved and relevant role at the immune 
system, regulating the expression of inducers and effectors in several points at the 
signaling pathways that define the response to pathogens. The range of NF-kB 
transcription factors, however, extends beyond the transcriptional regulation of immune 
responses, acting broadly to influence events of gene expression which have impact in 
cell survival, differentiation and proliferation (Hayden and Ghosh, 2008). Moreover, 
these transcription factors are found persistently active in a variety of disease states, 
including cancer, arthritis, chronic inflammation, asthma, neurodegenerative and heart 
diseases (Gilmore, 2014). 
The Rel/NF-kB proteins are structurally related through an highly conserved domain, 
responsible for DNA binding and homo/hetero-dimerization, known as Rel homology 
domain (RHD). Nevertheless, Rel/NF-kB proteins can be organized in two categories, 
based on their sequences: C-terminus sequences to RH domains. The members of the 
first class – p105, p100 and Drosophila Relish – present long C-terminal domains, 
which contain multiple copies of ankyrin repeats; members of this class become active 
by limited proteolysis or disrupted translation (p105 to p50 and p100 to p52) (Gilmore, 
2014). As a result, members of this class cannot act as transcription activators unless 
they dimerize with members of the second class, or with other proteins capable of 
recruiting co-activators (Hayden and Ghosh, 2008). The second class (the Rel 
proteins) include c-Rel, RelB, RelA (p65), Drosophila Dorsal and Dif, containing C-
terminal transcription activation domains (TAD) (Gilmore, 2014). 
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Figure 21 – The NF-kB family members and their structural features.  
The main feature of the NF-kB family members is the presence of a Rel Homology Domain 
(RHD). The presence or absence of a Transactivation Domain (TAD) separates the family 
members in two categories. The precursor proteins p100 and p105 function as both, inhibitors 
of nuclear factor-κB and, when processed by the proteasome, become NF-κB members. RHD – 
Rel Homology Domain; TAD – Transactivation Domain; LZ – leucine zipper domain; GRR – 
glycine-rich region; DD – death domain. Adapted from: (Ghosh and Hayden, 2008; Hayden and 
Ghosh, 2008) 
 
The Rel/NF-kB transcription factors bind to DNA sites of 9-10 base pairs – named 
kB sites – in the form of dimers. All vertebrate Rel proteins can form either homo or 
heterodimers, except RelB that can only form heterodimers (Gilmore, 2014). 
Particularly, the constitutive binding of p50 or p52 to kB sites at NF-kB-responsive 
promoters can act in order to verify NF-kB transactivation until they are dislocated by 
transcriptionally competent NF-kB dimers (Hayden and Ghosh, 2008). The combinatory 
diversity of homo and heterodimers that NF-kB proteins can form between them 
contributes to the regulation of distinct, but overlapping sets of genes, in which, 
individual dimers possess different specificities to DNA-binding sites in specific, but 
related, kB sites (Gilmore, 2014). Among the NF-kB dimers, the p50/p65 heterodimer is 
the biggest and most avidly forming Rel/NF-kB complex in most cells. Therefore, the 
NF-kB term will hereinafter be used referring to this particular heterodimer while 
Rel/NF-kB term will be used as a generic term, not referring to any particular dimer. 
In their inactive state, Rel/NF-kB dimers are found associated with one of the three 
typical IκB proteins IκBα, IκBβ or IkBε or to the precursor proteins p100 and p105, 
maintaining Rel/NF-kB dimers predominately “trapped” at the cytoplasm, thus acting as 
the main regulators of their activity. All IκB proteins are characterized by the presence 
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of multiple domains with ankyrin repeats. The prototypical and most studied member of 
this family is IκBα. IκBα is rapidly degraded during activation of Rel/NF-kB, leading to 
the release of several Rel/NF-kB dimers, despite the fact that p50/p65 is the most likely 
target of IκBα. The established model of IκB postulates that IκBα retains NF-kB dimers 
at the cytoplasm, thus preventing nuclear translocation and subsequent DNA binding. 
In fact, the crystal structure of IκBα bound to p50/p65 heterodimer reveals that IκBα 
protein masks only a nuclear localization sequence (NLS) of p65, while the NLS of p50 
remains exposed. The exposed NLS of p50 coupled with the nuclear export sequences 
(NES) of IκBα and p65 lead to a constant shuttling/redistribution of the IκBα/NF-kB 
complexes between the nucleus and cytoplasm, despite the steady-state location 
appearing to be almost exclusively cytosolic. On the other hand, degradation of IκBα 
(by phosphorylation events through IKK kinases) drastically alters the dynamic balance 
between cytosolic and nuclear signals, favouring the nuclear localization of the NF-kB 
dimers, thus allowing the transcriptional competent NF-kB dimers to bind to DNA at the 
previously mentioned kB sites. In the case of the repression of Rel/NF-kB dimers by 
p100, proteasomal processing of p100 to p52 takes place (instead of degradation), 
consequently releasing Rel/NF-kB dimers containing p52, which leads to a 
transcriptional response distinct from the one induced by IκBα - in part due to the fact 
that IκBα degradation and p100 processing regulate different populations of Rel/NF-kB 
dimers, therefore regulating distinct sets of genes (Hayden and Ghosh, 2008). 
Evoking once more the schematic representation of RIG-I signaling pathway 
depicted in Figure 13 it is discernible that, while the IRF3/IRF7 activation takes place 
through the actions of IKKε and TBK1, the removal of the IκBα repression from NF-kB 
cytosolic dimers occurs due to a different kinase complex: two highly homologue 
kinase subunits – IKKα and IKKβ – and NEMO, the regulatory subunit. In the majority 
of the classic NF-kB pathways (such as the one induced by RIG-I signaling), IKKβ is 
necessary and sufficient to phosphorylate IκBα at Ser32 and Ser36; IKKα can also 
mediate IκBα phosphorylation and cause its degradation, but it is not a necessary 
occurring step. The alternative/non-canonical pathways rely only on the IKKα subunit, 
which phosphorylates p100 causing the inducible processing to p52. It should be noted 
that the alternative pathway is activated by a subset of the Tumour Necrosis Factor 
Receptor (TNFR) superfamily while the canonical pathway is activated by a broader 
and overlapping set of receptors. The phosphorylation of serine residues at IκB 
proteins results in their K48-linked polyubiquitination by SCFβTrCP ubiquitin ligase 
complex in coordination with E2 UbcH5. The newly released NF-kB dimers can then 
bind to enhancer and promoter kB sites at the DNA sequence, allowing the interferon 
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response to take place. The termination of NF-kB response depends on the 
transcription of new IκB molecules that will interact with the competent NF-kB proteins 
bound to DNA sequences, trapping them once again mainly at the cytoplasm (Hayden 
and Ghosh, 2008). 
 
2.4.3 – IRF3/IRF7 & NF-kB recruitment and the assembly of the IFN-β 
“enhanceosome” 
Upon viral infection, the host cell requires three transcription factors in order to 
activate the transcription of the IFN-β gene: NF-kB, IRF3/IRF7 and ATF-2/c-Jun (Ford 
and Thanos, 2010; Honda et al., 2005). These necessary proteins to IFN-β induction 
are present in the cell prior to viral infection, but only upon viral infection they become 
activate to induce an adequate antiviral response (Honda et al., 2005). IRF3/IRF7 and 
NF-kB activation was already described above, but, unlike NF-kB and IRF-3/IRF-7, 
ATF-2/c-Jun (Activating transcription factor 2/c-Jun) is found in the nucleus and it is not 
able to activate transcription until its activation domain is phosphorylated by a MAPK 
signalling pathway [MAPK signalling pathway can be reviewed at (Jeffrey et al., 2007; 
Munshi and Ramesh, 2013)].  ATF-2 and c-Jun belong to the Fos-Jun family of bZIP 
proteins that possess a basic DNA-binding domain and a coiled-coil leucine zipper 
dimerization domain (Chinenov and Kerppola, 2001). It is important to note that ATF-
2/c-Jun requires the cooperative interactions with the other IFN-β activators to form a 
stable complex with DNA (Ford and Thanos, 2010). 
Interestingly, the oxidative state of the host cell also seems to be important for 
proper IFN-β transcription activation (Ford and Thanos, 2010). Specifically, IRF3 is S-
glutathionylated in non-infected cells but when a viral infection takes place, IRF3 is 
deglutathionylated by glutaredoxin-1 (GRX-1) (Prinarakis et al., 2008). The removal of 
glutathione moiety of IRF3 is necessary for the efficient interaction between IRF3 and 
its transcriptional co-activator CBP/p300 (Prinarakis et al., 2008). Therefore, a 
particular viral infection induces specific signalling cascades that result in post-
translational modifications (S-deglutathionylation and phosphorylation of IRF3/IRF7; 
ATF-2/c-Jun recruitment; removal of IkBα repression from NF-kB), necessary to the 
assembly of NF-kB, IRF3/IRF7 and ATF-2/c-Jun in a nucleic complex named 
“enhanceosome”.  
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For a clear comprehension of how the enhanceosome is assembled, it is first crucial 
to understand the concept of nucleosome and to explore the characteristics of the IFN-
β enhancer regions.  
Nucleosomes are the basic units of eukaryotic chromatin, composed of an histone 
octamer around which ~147bp of DNA is wrapped (Ford and Thanos, 2010). Each 
histone is made of two copies of histone proteins H2A, H2B, H3 and H4; histone tails at 
N-terminus extend from the central structure and are subject of covalent modifications 
like acetylation, phosphorylation and methylation (Kouzarides, 2007). These 
modifications are carried out by enzymes that are specifically recruited to the chromatin 
by regulatory transcriptional proteins and target the underlying genes for transcriptional 
activation or repression (Kouzarides, 2007). Histone modifications can also influence 
the nucleosome stability and provide an additional layer of information to the DNA 
sequence, in order to recruit additional regulatory transcription proteins (Bannister and 
Kouzarides, 2011; Kouzarides, 2007). The strategic nucleosome position throughout 
chromatin in selected genes can play a truly regulatory role in gene expression control; 
specifically, the phasing and the rotational or translational context of a given 
nucleosome can preferentially allow the binding of selected proteins to the adjacent 
DNA sequence, operating as a “gatekeeper” to access the DNA code (Schones et al., 
2008). 
The IFN-β enhancer is a DNA regulatory element of 50bp, localized between -104 
and -55bp upstream of the transcription initiation site; it contains four positive 
regulatory domains (PRDs) named PRDII, PRDIII-I and PRDIV that bind NF-kB, IRFs 
and the ATF-2/c-Jun heterodimer, respectively (Ford and Thanos, 2010; Sato, Tanaka, 
et al., 1998; Visvanathan and Goodbourn, 1989; Wathelet et al., 1998). Together with a 
high mobility group protein A1 (HMGA1), these activators bind cooperatively to DNA 
and form an exceptionally stable complex designated enhanceosome – activating 
transcription from the IFN-β promoter, in response to a given viral infection (Thanos 
and Maniatis, 1995; Wathelet et al., 1998; Yie et al., 1999). None of these activators 
and DNA elements alone are capable of activating transcription, thus, there’s 
something special about this enhancer region that limits the transcriptional potential of 
its positive regulatory elements (Ford and Thanos, 2010). Analysing each PRD of the 
IFN-β enhancer region it is possible to understand how this highly regulated promoter, 
the enhanceosome, operates (Ford and Thanos, 2010). 
PRDII site is recognized and bound by NF-kB transcription factor in the form of 
p50/p65 heterodimer with low affinity (Ford and Thanos, 2010). One of the reasons for 
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this low affinity seems to be an intrinsic bend in PRDII element that needs to be 
unfolded and aligned for a steadier NF-kB binding (Falvo et al., 1995). The chromatin-
associated protein HMGA1 increases greatly the affinity of NF-kB to PRDII site (Falvo 
et al., 1995). HMGA1 is a chromatin architectural protein that alters DNA structure 
upon binding to the minor groove; specifically, in the case of PRDII, HMGA1 reverses 
the intrinsic bend in DNA and creates a more favourable surface for NF-kB binding – 
DNA-induced allostery (Falvo et al., 1995). Thereby, studies and assays isolating 
PRDII site and studying it in and out of its natural context, NF-kB and HMGA1 showed 
to facilitate transcription through their cooperative binding to PRDII at the IFN-β 
enhancer (Falvo et al., 1995; Ford and Thanos, 2010).  
The PRDIV site of IFN-β enhancer binds an ATF-2/c-Jun heterodimer (Panne et al., 
2004).  As in the case of PRDII, PRDIV has an intrinsic bend of ~25o that is reduced to 
about 15o upon binding of HMGA1 (Falvo et al., 1995). The ATF-2/c-Jun binding 
reduces this bend in a way that the helix axis becomes almost straight, with some 
localized distortions required for a cooperative binding (Panne et al., 2004). Once 
again, HMGA1 binding proves to be essential for virus-induced activation of IFN-β gene 
(Falvo et al., 1995; Panne et al., 2004).  
PRDIII-I site is the binding site of IRF3 and IRF7 proteins, yet, IRF1 was the first 
protein that was shown to bind to PRDIII-I (Ford and Thanos, 2010; Fujita et al., 1989). 
However, while IRF1 expression can indeed activate IFN-β transcription, it is not able 
to do it in a way that is consistent with virus activation alone (Reis et al., 1994). On the 
other hand, the IFN-β expression is severely deficient in mouse cells without IRF3 or 
IRF7, and it is pretty much undetectable in IRF3/IRF7 double knockout cells (Sato et 
al., 2000). Remarkably, IRF3 is constitutively expressed, phosphorylated upon viral 
infection and then dimerizes and translocates to the nucleus, while IRF7 is only 
expressed in low levels at first (Sato et al., 2000). Only after secretion of IFN-β, a signal 
cascade is induced to result in the expression of higher levels of IRF7 (Sato et al., 
2000). Despite the differences between mouse and human cells, as well as the 
variability between cell lines, the bigger picture drawn by in vitro binding studies, 
transcription assays in human cells and knockout mouse models points to a model 
where high levels of IRF3 and low levels of IRF7 activate the initial IFN-β transcription 
that is then followed by a secondary stage with high levels of IRF7 expression, not 
requiring IRF3 (Reis et al., 1994; Sato et al., 2000).  
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2.4.4 – IFN-β enhanceosome assembly  
Taking in consideration the data described above, several crystal structures of DNA-
binding domains (DBDs) of proteins found in the enhanceosome have been resolved: 
the NF-kB p50/p65 heterodimer bound to PRDII, IRF1 bound to PRDI, IRF3 bound to 
PRDIII-I, ATF-2/c-Jun and IRF3 bound to a composite of PRDIV-PRDIII as well as 
p50/p65 and IRF7 bound to a composite of PRDI-PRDII (Berkowitz et al., 2002; 
Escalante et al., 1998; Panne et al., 2004, 2007; Qin et al., 2005). Using these 
structures and overlapping them, the entire enhanceosome, with the exception of 
HMGA1, has been deciphered, supporting the aforementioned biochemical models 
(Panne et al., 2007). In particular, ATF-2/c-Jun binds to PRDIV site with ATF-2 
upstream and c-Jun downstream; four IRF molecules are bound to PRDIII-I site in the 
form of IRF3 homodimers or in the form of IRF3/IRF7 heterodimers – two IRF 
molecules bind as a dimer in one side of the DNA helix at the PRDI and PRDIII 
consensus sites and, at the opposite side of the helix, a second IRF dimer binds to 
non-consensus sites traversing the PRDI and PRDIII sites; and lastly, p50/p65 binds to 
PRDII site with p50 subunit upstream and p65 facing the central promoter (Panne et 
al., 2007). 
An interesting feature to take into account during the enhanceosome assembly is 
the role that HMGA1 plays, since the crystal structures and biochemical data conflict at 
this point. HMGA1 binds to DNA at the minor groove through AT-hooks – each HMGA1 
molecule contains three flexible AT-hooks DNA-binding domains (DBDs) (Reeves and 
Beckerbauer, 2001; Yie et al., 1997). An initial HMGA1 molecule binds to PRDIV site 
through its first and second DBDs, while a second HMGA1 binds to PRDII composite 
using its second and third DBDs (see Figure 22) (Yie et al., 1997). Curiously, the 
crystal structures show that one of the HMGA1 binding sites to PRDIV is obstructed by 
IRF7; at the PRDII site, p50/p65 binding distorts the DNA helix in a way that the minor 
groove becomes probably too narrow to accommodate a simultaneous binding to 
HMGA1 as well (Ford and Thanos, 2010). This could lead to the assumption that 
HMGA1 exerts its functions in a “hit and run” mechanism, that is, facilitating the 
enhanceosome assembly but not being present in the final structure (Ford and Thanos, 
2010). However, HMGA1 was observed in the complete form of the enhanceosome, 
making direct contacts with NF-kB and ATF-2 (Yie et al., 1999). Besides, HMGA1 
remains associated with IFN-β promoter from the time NF-kB is initially recruited till the 
end of IFN-β transcription (Ford and Thanos, 2010). Thus, it seems likely that the final 
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enhanceosome structure might be slightly different than the one that crystal resolutions 
have shown so far, or, perhaps, HMGA1 can be retained at the enhancer through 
protein-protein interactions (Ford and Thanos, 2010).  
 
2.4.5 – Enhanceosome apparatus – the pre-initiation complex 
The newly assembled enhanceosome creates a tree-dimensional surface that is 
initially recognized by the co-activator protein PCAF (p300/CBP-associated factor) 
(Agalioti et al., 2000). In spite of the fact that the IFN-β enhancer is directly flanked by 
nucleosomes in both sides, the enhancer sequence itself is nucleosome-free (Agalioti 
et al., 2000). Upon recruitment, PCAF acetylates a small subset of lysines at the 
histone tails of H3 and H4 at the adjacent nucleosomes, specifically the acetylation of 
H4K8 and H3K9 (Agalioti et al., 2002). This event is followed by phosphorylation of 
Ser10 at H3 by an unknown enzyme that, in turn, allows acetylation of H3K14 (Agalioti 
et al., 2002). In in vitro acetylation assays, PCAF reveals low substrate specificity, thus, 
the tree-dimensional configuration of the enhanceosome might position PCAF within 
this pre-initiation complex and convert it from a relatively unspecific enzyme into an 
enzyme with high levels of specificity – proving evidence of how an unique combination 
of activators can result in the generation of a very specific signal (Agalioti et al., 2002).  
The combination of acetylation of histones is then recognized by a specific set of 
factors (Agalioti et al., 2002). At this point, PCAF is released and replaced by CREB-
binding protein (CBP), which is recruited in the form of a complex with the holoenzyme 
RNA polymerase II (Pol II), containing Transcription Factor II E (TFIIE), TFIIH, TFIIF 
and SWI/SNF (SWItch/Sucrose Non Fermentable) (Figure 22) (Agalioti et al., 2002; 
Kim et al., 1998). Despite CBP being able to form a complex with each one of the 
activators of the enhanceosome alone, the tree-dimensional geometry creates a 
contiguous surface that facilitates cooperative binding of CBP with the enhanceosome, 
necessary for the synergic transcription of IFN-β (Merika et al., 1998). 
 
 
 
Universidade de Aveiro                                             Mitochondria and Peroxisomes: role within  
cellular antiviral defense 
 
  
Mariana Guedes   89 
 
 
 
Figure 22 – Assembly of the IFN-β enhanceosome. 
a) The naked enhancer DNA with its intrinsic curve. b) A specialized Alu element with a NF-kB 
binding site delivers NF-kB to the IFN-β enhancer. c) NF-kB binds to the IFN-β enhancer 
cooperatively with HMGA1 and reverses the intrinsic bend in the DNA at the PRDII site. d) ATF-
2/c-Jun and IRF3/IRF7 bind in highly cooperative fashion along with NF-kB and HMGA1. e) 
PCAF is recruited to the enhancer and acetylates HMGA1 and histones H3 and H4. f) A CBP-
PolII holoenzyme complex replaces PCAF, SWI/SNF remodels the adjacent nucleosome. g) 
TFIID (TBP) binds and induces nucleosome sliding. h) CBP acetylates HMGA1 and the 
enhanceosome proteins disassociate from the enhancer. (Ford and Thanos, 2010) 
 
 
The IFN-β promoter has a nucleosome positioned on top of the transcription 
initiation site, directly adjacent to the TATA box (Agalioti et al., 2000). This is a common 
arrangement at the promoter that – together with the fact that transcriptional machinery 
cannot operate on nucleosome-bound DNA – underlines the importance of the local 
chromatin structure in the regulation of transcription (Agalioti et al., 2000). In order to 
overcome the barrier presented by the nucleosome positioned at the initiation site, the 
ATP-dependent nucleosome-remodelling SWI/SNF complex is recruited to the 
promoter through the interaction with CBP (Agalioti et al., 2000). The SWI/SNF BRG1 
and BRM subunits possess bromodomains that specifically recognize the acetylated 
forms of the histone tails (Agalioti et al., 2000). The SWI/SNF complex promotes the 
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twisting and “peeling off” the DNA, in order to allow the binding of TFIID (Lomvardas 
and Thanos, 2001). Upon TFIID binding to DNA, a TATA-binding protein (TBP) induces 
a major DNA bending that causes the nucleosome to slide 36bp below its original 
position (Lomvardas and Thanos, 2001). With the TATA box now exposed, the IFN-β 
gene expression events can take place, culminating at this point in the production of 
interferon β proteins. 
 
2.4.6 – The intricate regulation of IFN-α genes 
The IFN-α genes are also transcriptionally induced in response to viral infections in 
a similar way to IFN-β, requiring serine-phosphorylated proteins for its expression (Sato 
et al., 2000). In some ways, IFN-α is less complex than IFN-β gene expression, since 
the only well-characterized enhancer elements that control IFN-α genes contain IRF-
binding sites – with no apparent contribution of NF-kB or ATF-2/c-Jun complexes (Sato 
et al., 2000). The IFN-α genes negative regulation also appears to operate greatly 
through the inhibition of IRF proteins (Levy and Marié, 2005).  
It is not yet clear if the IFN-α genes transcription involves the formation of an 
enhanceosome structure, DNA bending or nucleosome repositioning; it is, however, 
known that a competitive binding between IRF2 and activating members of IRF family 
keep the basal levels of IFNs, observed in the absence of viral infection (Levy and 
Marié, 2005). The repressor Pitx1 homeobox also seems to contribute to the silencing 
of IFN-α gene, through its ability to interact and inhibit IRF3 and IRF7 (Island and 
Mesplede, 2002).     
Despite the deceptive simplicity of a regulatory scheme that only requires one type 
of transcriptional activator, there’s a complexity aspect that is not observed with IFN-β 
(Levy and Marié, 2005). It was discovered that IFN-β and the multigenic family of IFN-α 
are not regulated in unison during a viral infection, and that their differential expression 
is, at least in part, regulated through a positive feedback loop involving the induction of 
IRF proteins (Marié et al., 1998; Sato, Hata, et al., 1998). IFN-β and the mouse IFN-α4 
isotype are induced with early kinetics through the actions of the constitutively 
expressed IRF3 (Marié et al., 1998). On the other hand, enhancers from other 
members of the IFN-α family aren’t able to bind IRF3, but instead, are only activated by 
IRF7 (Levy and Marié, 2005). IRF7, as previously stated in this chapter, is not 
constitutively expressed in most cell lines and its expression is induced by the IFN 
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signaling through the JAK-STAT pathway (Mamane et al., 1999). Thus, in response to 
the initial IFN-β and IFN-α4 secretion through the actions of IRF3, the IRF7 induction 
renders cells sensible to the induction of additional subtypes of IFN-α (commonly 
referred as the non-IFN-α4 subsets of genes), ultimately leading to a robust production 
of several species of IFN-α and a consequent powerful antiviral activity (Marié et al., 
1998; Sato, Hata, et al., 1998). 
 
 
Figure 23 – Schematic model of the IFN gene induction in virus infected cells. 
 A) Activation of immediate-early genes: following virus infection or treatment with dsRNA, a 
coordinate activation of different transcription factors occurs through the activation of distinct 
signalling pathways that lead to virus-induced phosphorylation (P). These factors act 
synergistically at the IFN-β enhanceosome together with the co-activator CBP/p300 and the 
chromatin remodelling protein HMG1. In murine cells, activated IRF3 also upregulates IFN-α4 
gene expression. B) Activation of delayed-type genes: secreted IFN from virus-infected cells 
acts in an autocrine or paracrine fashion through binding to the type I IFN receptor. Activation of 
the JAK-STAT signalling pathway induces the formation of the ISGF3 complex, which leads to 
the expression and activation of IRF7. In turn, IRF7 participates in the induction of delayed-type 
IFNs, resulting in the amplification of IFN gene expression. Transcribed from: (Mamane et al., 
1999) 
 
 
Additional reports have suggested another level of complexity in the regulation of 
IFN-α induction. In the same way that IRF3 and IRF7 presence and activation 
programs the induction of a diversity of IFN-α genes subtypes, other members of the 
IRF family seem to target specific IFN-α isotypes; particularly, it was found that IRF5 
can participate in IFN-α genes induction by certain viruses, such as the Newcastle 
 
 
Universidade de Aveiro                                            Mitochondria and Peroxisomes: role within  
cellular antiviral defense 
 
 
92           Mariana Guedes 
 
Disease Virus (NDV), leading to the preferential induction of the human IFNA8 gene 
(Barnes et al., 2001).  
 
2.4.7 – The IFN-dependent JAK-STAT pathway activation and ISG 
production 
All interferons exert their effects by binding to specific surface receptors, leading to 
the activation of signalling pathways that ultimately target the induction of interferon-
stimulated genes (ISGs), whose proteins mediate the antiviral effects (Fensterl and 
Sen, 2009). 
Type I IFNs bind to a common surface receptor know as type I interferon receptor; it 
possesses two subunits, IFNAR1 and IFNAR2 and each one of these subunits 
interacts with a member of the Janus Activated Kinase (JAK) family. IFNAR1 is 
associated with tyrosine kinase 2 (TYK2) while IFNAR2 is associated with JAK1 
(Platanias, 2005). 
The binding of IFN-α or IFN-β to the type I IFN receptor results in the 
autophosphorylation and activation of the associated JAKs, TYK2 and JAK1, that, in 
turn, regulate the phosphorylation and activation of Signal Transducers and Activators 
of Transcription (STATs). STATs are latent cytosolic transcription factors that become 
active upon phosphorylation by the Janus kinases. In response to type I IFN 
stimulation, activated STATs include STAT1, -2, 3 and -5. STAT4 and -6 can also be 
activated by IFN-α but only on certain cell types such as endothelial cells of lymphoid 
cells. Upon phosphorylation by JAKs, the activated STATs can form homo- or 
heterodimers that translocate to the nucleus and initiate transcription by binding to 
specific sites at the ISGs promoters (Platanias, 2005). 
Worthy of note is the formation of the ISG factor 3 complex, composed of the active 
forms of STAT1 and STAT2, together with IRF9. This is an unique complex that binds 
to specific genic elements known as IFN-stimulated response elements (ISREs), 
presented at the promoter region of certain ISGs, thus initiating their transcription. 
Other types of complexes can bind to another type of element, known as Gamma 
interferon Activation Sites (GAS) in other ISGs promoter regions. This is particularly 
important, given that some ISGs only possess ISREs, others just the GAS and others 
can have both, thus, the combination of different STAT complexes allows a differential 
and optimal gene transcription (Platanias, 2005).  
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Figure 24 – Activation of classical JAK-STAT pathways through IFN receptors by type I 
and type II interferons.  
All type I interferons bind a common receptor at the surface of human cells, which is known as 
the type I IFN receptor. This receptor is composed of two subunits, IFNAR1 and IFNAR2, which 
are associated with TYK2 and JAK1 respectively. The type II IFN, IFNγ, binds a distinct cell-
surface receptor, known as the type II IFN receptor, which also has two subunits, IFNGR1 and 
IFNGR2 that are associated with JAK1 and JAK2 respectively. Activation of the JAKs that are 
associated with the type I IFN receptor results in tyrosine phosphorylation of STAT2 and 
STAT1, leading to the formation of STAT1-STAT2-IRF9 complexes, that are known as ISGF3 
complexes. These complexes translocate to the nucleus and bind to ISREs in DNA to initiate 
gene transcription. Both, type I and type II IFNs also induce the formation of STAT1-STAT1 
homodimers that translocate to the nucleus and bind GAS elements that are present in the 
promoter of certain ISGs, thereby initiating the transcription of these genes. N – any nucleotide. 
(Platanias, 2005) 
 
 
 The transcriptional activation of ISGs leads to the production of antiviral effector 
proteins. To date, three antiviral pathways were strongly established: the Protein 
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Kinase K (PKR), the 2-5 OAS/RNaseL system and the Mx proteins (Haller et al., 2006). 
However, other ISGs action mechanisms have been discovered in the past years, such 
as APOBEC3G, ISG15, IFIT1/2/3, viperin (also known as RSAD2), etc. (Schoggins and 
Rice, 2011). 
The dsRNA-activated kinase protein PKR is induced by interferons but it is 
constitutively expressed in low levels in most cell types. Its activation occurs after 
binding of dsRNA inducing its dimerization and auto-phosphorylation. PKR then 
phosphorylates the translation initiator factor eIF-2α, resulting in its cellular and viral 
inhibition. PKR inhibits replication of most RNA viruses such as Vesicular stomatitis 
virus (VSV), Encephalomyocarditis virus (EMCV), West Nile virus (WNV), hepatitis C 
virus (HCV), and DNA viruses such as Herpes simplex virus 1 (HSV-1) (Fensterl and 
Sen, 2009). 
Another type of IFN-induced enzymes is the 2’-5’-oligoadenilatesinthetases (such 
as OAS1) that, upon binding with dsRNA generate 2’-5’-linked AMP oligomers from 
ATP; these activate RNase L which dimerizes and cleaves cellular and viral ssRNA, 
preventing protein expression and occasionally induces apoptosis. This system is the 
main effector against picornaviruses and influenza A viruses. Furthermore, cellular 
cleaved RNAs can amplify the interferon induction serving as ligands of RIG-I. The 
unspecific cleavage of ssRNA can also occur after ISG20 induction, a 3’-
exoribonuclease that inhibits VSV viruses (Fensterl and Sen, 2009). 
Mx1 (a.k.a. MxA) uses a peculiar mechanism by disrupting cell membranes around 
the nucleus, binding to viral nucleocapsids, thus inhibiting viral intracellular trafficking. It 
is the main feature against orthomyxoviruses such as influenza viruses and others 
such as measles virus, VSV, Hantavirus and Semliki Forest virus (Fensterl and Sen, 
2009). 
The nucleic acid-editing APO-BEC3G and -3F are deoxyxytidine deaminases that 
inhibit retroviruses, acting through the introduction of C or U mutations within the viral 
reverse DNA thus, directly interfering with reverse transcription (Fensterl and Sen, 
2009).  
Members of the human gene family ISG56 (IFIT1) are highly induced by IFN, 
dsRNA or viral infection. Four members comprise this gene family, among them the 
IFIT1/ISG56, IFIT2/ISG54, IFIT4/ISG60 and IFIT5/ISG58. They all encode proteins with 
multiple tetratricopeptide motifs which are protein-protein interaction motifs that act in 
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combination. These proteins bind to eIF-3; the binding of P56 proteins to eIF-3 causes 
the inhibition of initiation of protein synthesis (Sen and Sarkar, 2007).  
ISG15 is another human gene highly induced by IFN, dsRNA and viruses. It 
encodes an ubiquitin-like protein named P15 and, like ubiquitin, it binds to target 
proteins by isopeptide linkages between lysine chains of their targets. The functional 
consequences of ISG15ylation are still to be determined; a study revealed that NS1B 
protein of influenza B virus specifically blocks ISGylated proteins suggesting that this 
process allows the virus to evade the effect of ISG15. Another study shows that ISG15 
is the protein that mediates IFN action against HIV-1 morphogenesis; IFNs inhibit the 
HIV-1 virion release without affecting protein synthesis and these effects can be 
mimicked by ectopic expression of ISG15 and its activating enzymes (Sen and Sarkar, 
2007).  
Viperin can interfere with the envelope budding process of cytomegaloviruses 
(HCMV), HCV and influenza by disrupting lipid rafts at the membrane; however, the 
precise action mechanism is yet to be determined (Fensterl and Sen, 2009). 
The number of ISGs is endless and their action mechanisms remain elusive. This 
reveals a special feature of the antiviral immune system: it acts by coordinating the 
actions of several effector molecules with a less powerful effect instead of falling back 
on only a few powerful effectors. Inducing a range of weak effectors in detriment of 
upregulating a small group of powerful genes might in fact be preferable from the host 
perspective, once the latter could result in cellular toxicity (Schoggins and Rice, 2011).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Universidade de Aveiro                                            Mitochondria and Peroxisomes: role within  
cellular antiviral defense 
 
 
96           Mariana Guedes 
 
 
 
 
 
 
Universidade de Aveiro                                             Mitochondria and Peroxisomes: role within  
cellular antiviral defense 
 
  
Mariana Guedes   97 
 
3 – Viral strategies of survival – subverting key points in the antiviral RLR 
signalling pathway  
The mechanisms employed by viruses to escape innate immune responses, 
particularly, the type I IFN induction system through detection by cytosolic receptors 
(the RLR signalling pathway) rely in the subversion of key aspects of such pathways. 
The most direct mechanism is to avoid initial detection, via mechanisms that interfere 
with viral recognition. Some viruses count on the circumvention of components of the 
signalling pathways which lead to IFN production and, lastly, others resort to 
mechanisms that inhibit IFN-induced antiviral effector proteins. 
3.1 - Viral mechanisms that subvert viral recognition 
Some viruses are able to hide or degrade their own genomes. For example, tick-
borne encephalitis virus delays cellular signalling by sequestering their RNA molecules 
into membrane compartments at the cytosol, where they cannot be accessed or 
recognized by PRRs (Miorin et al., 2012); the Japanese Encephalitis virus (JEV) can 
also hide its dsRNA in intracellular membranes. Instead of hiding it, Lassa Fever virus 
uses the 3’-5’-exonuclease activity of its nucleoprotein to digest its own dsRNA (Hastie 
et al., 2011), while the C protein of the human parainfluenza type 1 is thought to 
regulate the production of its own RNA in order to prevent it from accumulating within 
the cell (Boonyaratanakornkit et al., 2011).  
RLRs, like other viral detection receptors can be hampered by viruses:  
- The human Respiratory Syncytial virus (RSV) N protein inhibits both RIG-I and 
MDA5 (Lifland et al., 2012) while the HIV protease decreases the cytosolic levels 
of RIG-I, targeting it to lysosomes (Solis et al., 2011);  
- Arenavirus nucleoproteins and Z proteins of the New World Arenaviruses were 
shown to bind to RIG-I and inhibit subsequent downstream signalling (Borrow et 
al., 2010); 
- Toscana virus-derived non-structural proteins (NSs) interact with RIG-I, leading to 
its proteasomal degradation (Gori-Savellini et al., 2013); 
- V proteins of paramyxoviruses promote interactions between RIG-I and LGP2 
(Childs et al., 2012); 
- Several viral proteins (i.e.: Arterivirus NS2 (van Kasteren et al., 2012), Kaposi 
Sarcoma-associated herpesvirus ORF64 (Inn et al., 2011), etc.) target RIG-I 
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through deubiquitinating enzymes (DUBs) that remove K63-linked ubiquitin chains 
from RIG-I, preventing its interaction with MAVS adaptor. 
 
 
Figure 25 – The RLR pathway and viral inhibitors.  
Several viral proteins/factors are capable of influencing and subverting the antiviral response by 
disrupting the RLR pathway in crucial points. DUBs – deubiquitinases; RSV - Respiratory 
Syncytial virus; HIV – Human Immunodeficiency virus; NWA - New World Arenaviruses; KSHV - 
Kaposi Sarcoma-associated herpesvirus; HPV – Human Papilloma virus; Sev – Sendai virus; 
SFTSV - Severe Fever with Thrombocytopenia Syndrome virus. 
 
 
 
Universidade de Aveiro                                             Mitochondria and Peroxisomes: role within  
cellular antiviral defense 
 
  
Mariana Guedes   99 
 
3.2 – Evasion mechanisms of RLR pathway components that lead to IFN 
production 
MAVS adaptor is a common target for antiviral antagonists. PB1-F2 protein of 
influenza A virus binds to the transmembrane domain of MAVS leading to a drop in the 
mitochondrial membrane potential, required for MAVS functions (Varga et al., 2012). 
The coxsackievvirus B3 codes a cysteine protease 3Cpro and hepatitis C virus NS3/4A 
protein both cleave MAVS directly  while HBx protein of hepatitis B virus associates 
with, and blocks MAVS (Kumar et al., 2011; Li et al., 2005; Mukherjee et al., 2011). 
STING is also affected by viral proteins such as the protease complex NS2B3 of 
Dengue virus, cleaving STING in two inactive fragments (Yu et al., 2012). Papain-like 
proteases of human coronavirus NL63 and SARS-CoV that possess DUB and protease 
activities disrupt STING dimerization by increasing its ubiquitination levels (Sun et al., 
2012). 
It has been shown that IRF3 is a target for the viral protein E6 of human papilloma 
virus (HPV); Ronco et al. demonstrated that E6 interacts with IRF3 and compromises 
its ability to transcriptionally activate IFN-β production (Ronco et al., 1998). Talon et al. 
also demonstrated that influenza A prevents IRF3 activation by a mechanism 
dependent upon the viral protein NS1 (Talon et al., 2000). The V protein of Sendai 
virus binds directly to IRF3, jeopardizing its functions (Ye and Maniatis, 2011); Varicella 
zoster virus induces an atypical TBK1-independent IRF3 phosphorylation, blocking the 
downstream dimerization and its activity through the serine-threonine kinase protein 
ORF47 (Vandevenne et al., 2011); ORF61, also from varicella zoster virus, specifically 
interacts with activated and phosphorylated IRF3, using a RING-finger E3 ubiquitin 
ligase domain to ubiquitinate and degrade IRF3 via the proteasomal degradation (Zhu 
et al., 2011). 
Several viral proteins are able to disrupt IRF3 activation via indirect mechanisms, by 
interfering with TBK1 and IKKε kinases. Paulmann et al. demonstrated that infection by 
hepatitis A virus inactivates TBK1 (Paulmann et al., 2008). TBK1 can also activate 
IRF7 inducing the production of IFN-α, and Paulmann group showed that virus-derived 
proteins 2B and 3ABC interact with MAVS and block TBK1 activity (Paulmann et al., 
2008) Their findings also suggest an interaction between 2B and IKKε (Paulmann et 
al., 2008). Despite the exact mechanisms remaining elusive, the NS proteins of Severe 
Fever with Thrombocytopenia syndrome virus (SFTSV) and the HSV-1 y34.5 protein 
associate with and inhibit TBK1 (Ma et al., 2012; Qu et al., 2012). The A59 papain-like 
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protease domain 2 of the protein NSp3 of mouse hepatitis virus was found to 
deubiquitinate TBK1, decreasing its kinase activity, stabilizing it in an inactive 
conformation (Wang et al., 2011). The C6 protein of Vaccinia virus interferes with 
IRF3/IRF7 activation at the level of TBK1/IKKε through interaction with TANK, NAP1 
and SINTBAD proteins (recalling that the contribution of these proteins to antiviral 
signalling is yet not clear) (Unterholzner et al., 2011). The NP proteins of several 
arenaviruses are capable of association with the kinase domain of IKKε, by encoding a 
miRNA known as miR-K12-11 that under regulates the mRNA translation of IKKε 
(Liang et al., 2011; Pythoud et al., 2012).  
IRF7 can also be hampered by viruses: some strains of rotavirus use their NSP1 
protein to cause IRF7 degradation via the proteasome, while other strains target IRF3 
and IRF5, or even the β-TrCP protein, a component of the E3 ubiquitin ligase complex 
that activates NF-kB (Arnold and Patton, 2011). IRF7 is inhibited by competitive 
inhibition with ORF45 of Kaposi's sarcoma-associated herpesvirus (KSHV), which 
hinders IRF7 phosphorylation and activation, since it is more effectively phosphorylated 
by TBK1 and IKKε than IRF7 (Liang et al., 2012). ORF45 can also block IRF7 by 
association with its inhibitory domain, stabilizing auto-inhibitory interactions to keep the 
protein under a closed conformation (Sathish et al., 2011). In macrophages and 
dendritic cells, the VP35 protein of Ebola virus interferes with IRF7 activation through 
the RLR pathway while in plasmacytoid dendritic cells, VP35 does not block IFN 
production, since this cell type activates IRF7 through TLR pathway (Leung et al., 
2011). 
The KSHV express their own IRF proteins (vIRF) that possess a high homology with 
the cell IRFs; vIRF1 and vIRF2 of KSHV inhibit IRF3 and, subsequently impair IFN-β 
production (Devasthanam, 2014). 
It has been reported that the 3C viral protein of poliovirus is able to cleave RelA 
subunit and functionally inactivate NF-kB in HeLa cells; RelA cleavage was also 
demonstrated for other viruses of the poliovirus family, suggesting that RelA cleavage 
can be a conserved characteristic within this virus family (Neznanov et al., 2005). 
Another example of viral disruption of NF-kB involves the V protein of measles virus 
that binds to the nuclear localization signal of RelA, compromising its nuclear 
translocation (Schuhmann et al., 2011). NEMO is also a target of cleavage, since its 
cleaved into inactive fragments by 3Cpro protease of foot-and-mouth disease virus 
(Wang, Fang, Li, et al., 2012). 
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Less understood is the viral action upon ATF2/c-Jun but a viral blockage was 
already described: the VP24 protein of Zaire Ebola virus prevents MAP kinase p38 
phosphorylation (a precursor of ATF2 activation) and subsequent ATF2 activation 
(Halfmann et al., 2011). 
 
3.3 – Inhibitory mechanisms of IFN downstream pathway components and 
IFN-induced effectors  
Targeting the JAK-STAT pathway seems to be a commonly used strategy of viral 
subversion of the host attempts to fight viral replication. This is particularly true for a 
diverse group of viruses that express V and C proteins. The Paramyxovirus including 
measles, mumps and Hendra viruses express V proteins capable of blocking IFN-β 
induction. However, V proteins aren’t exclusive of paramyxoviruses: SV5 product of 
rubella virus has been shown to reduce the half-life of STAT proteins (Ulane and 
Horvath, 2002); V protein of Hendra virus is able to capture STAT proteins in large 
cytosolic complexes and limit their nuclear translocation (Rodriguez et al., 2003); 
measles-infected cells were found to be non-responsive to IFN-α but still responsive to 
IFNγ (Yokota et al., 2003); Yokota et al. investigated this and demonstrated that the V 
protein prevents the phosphorylation of JAK1 and the C protein binds to and 
incapacitates IFNAR1, preventing the IFN-α downstream events(Yokota et al., 2003). 
Likewise, the C proteins also target the JAK-STAT pathway. C protein of Sendai 
virus was shown to inhibit STAT1 phosphorylation (Garcin and Marq, 2003); other 
studies also suggest that C protein of Sendai virus renders cells unresponsive to type I 
and type II interferons – Gotoh et al. found that C proteins interact with the 
phosphorylated forms of STAT1 and STAT2, reducing their ability to form homo- and 
heterodimers (Gotoh et al., 2003). 
The human metapneumovirus reduces JAK1 and TYK2 mRNAs and proteins, 
leading to a diminished IFNAR expression by means of increased internalization, 
possibly due to the loss of TYK2 (Ren et al., 2011). E6 and E7 proteins of HPV 
interfere with STAT1 promoter to block its transcription (Hong et al., 2011); C protein of 
human parainfluenza virus type 1 prevents the nuclear translocation of STAT1, 
physically retain it at the cytosol in perinuclear aggregates associated with endosomal 
markers (Boonyaratanakornkit et al., 2011). vIRF2 of KSHV decreases STAT1 and 
IRF9 levels by compromising the functions of ISGF3 (Mutocheluh et al., 2011). HSV-2 
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causes the selective loss of STAT2 transcripts and proteins in some cell types while in 
others, the STAT2 levels remain constant by their phosphorylation and nuclear 
translocation are inhibited (Kadeppagari et al., 2012). Adenovirus on the other hand 
stabilizes the activated STAT1, capturing it in centres of viral replication, possibly 
through binding to viral DNA (Sohn and Hearing, 2011). Adenovirus also hampers 
dephosphorylation of STAT1 obstructing its interaction with the tyrosine phosphatase 
TC45 (Sohn and Hearing, 2011). 
SOCS proteins are known for their ability to negatively regulate the JAK-STAT 
pathway. Bode et al. demonstrated in HepG2 cells that the core viral protein of HCV 
induces expression of SOCS3 (Bode et al., 2003). Pothlichet et al. revealed that, in 
respiratory epithelial cells infected with influenza A, the expression of SOCS1 and 
SOCS3 is induced (Pothlichet et al., 2008). Besides, expression of SOCS was only 
observed in signalling pathways were RIG-I and IFNAR1 were intact, suggesting that 
this mechanism has a late effect in the course of the infection (Pothlichet et al., 2008). 
Fonseca et al. demonstrated that the antiviral activity requires mono-ubiquitination of 
histone 2B at lysine 120, a post-translational modification associated with 
transcriptionally activated chromatin in both, the ISG regions and their promoter 
regions (Fonseca et al., 2012). They also found that E1A protein of the human 
adenovirus disrupts the hBrel complex, responsible for the mono-ubiquitination of H2B, 
preventing ISGs expression and allowing the escape of the antiviral signalling 
(Fonseca et al., 2012). Another study by Marazzi et al. demonstrated that the NS1 
protein of the H3N2 strain of influenza A virus has a short sequence that mimics the tail 
of the histone H3; this allows histone modification enzymes to act at NS1 protein (NS1 
is acetylated and methylated in infected cells); the modified NS1 associates with the 
elongation complex of transcription PAF1, allowing the virus to sequester the 
elongation machinery (Marazzi et al., 2012). NS1 also disrupts transcriptional 
elongation in antiviral active genes, selectively jeopardizing ISGs expression (Marazzi 
et al., 2012). 
Instead of globally obstructing the ISGs expression, some viruses target specific 
ISGs, such as the HCV infection that upregulates microRNA that decreases the 
expression of IFITM1 (Bhanja Chowdhury et al., 2012); ORF94 of HCMV blocks the 
expression and activity of OAS (Tan et al., 2011). Instead of interfering directly against 
OAS, Mouse Hepatitis Virus (MHV) uses NS2 protein, preventing the activation of 
RNaseL (L. Zhao et al., 2012). NS2A of JEV interacts physically with PKR to prevent its 
activation (Tu et al., 2012); poliovirus overcomes translational inhibition of PKR by 
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cleaving a eukaryotic initiation factor eIF5B, creating a cleavage fragment that is able 
to restore viral translation (White et al., 2011). 
In particular cases, some viruses remarkably explore their host cell resources, using 
particular ISGs to their own advantage. In example, HSV-1 stimulates an isoform of 
MxA by alternative splicing in the absence of type I IFNs; this new isoform associates 
with components of the virion and compartments of nuclear viral replication, increasing 
viral replication (Ku et al., 2011). HCMV is long known for its ability to directly induce 
viperin expression in the absence of IFNs production (Seo, Yaneva, and Cresswell, 
2011). It was recently demonstrated that, through interactions with the viral protein 
vMIA, viperin is relocated to mitochondria where it disrupts the actin cytoskeleton and 
increasing viral infection (Seo, Yaneva, Hinson, et al., 2011). Another curious example 
is the one of rotaviruses in intestinal epithelial cells, where it induces a strong induction 
of the type I IFN response, but, instead of limiting its growth, the IFN signalling 
promotes replication of rotavirus, especially in early stages (Frias et al., 2012). 
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4 – Peroxisome-dependent Antiviral Signalling – via the MAVS adaptor 
 Until recently, mitochondria were the single key organelle implicated in the RLR 
antiviral pathway. Notwithstanding, the results from Dixit et al. (2010) changed this 
perception, as they introduced an unexpected new player into this antiviral signaling 
pathway: the peroxisomes (Dixit et al., 2010).  
4.1 - Discovery of the peroxisomal MAVS adaptor: first insights into this novel 
antiviral signalling platform 
As aforementioned in the Introduction chapter, mitochondria and peroxisomes share 
several features and proteins (Schrader and Yoon, 2007). Among them, Mff and Fis1 
share similarities in their sequence with the MAVS adaptor (Camões et al., 2009; Dixit 
et al., 2010)  Exploring the implications of such similarities, Dixit et al. 2010 reported for 
the first time that MAVS can also be found in peroxisomes. 
The main findings of this study revealed the localization of MAVS proteins anchored 
to the membrane of peroxisomes and a functional signaling pathway that operates 
through peroxisomal MAVS. Such pathway establishes an immediate yet transient 
antiviral response when compared with the mitochondrial MAVS pathway. Furthermore, 
the authors suggest that this novel peroxisomal pathway might result in an ISG 
induction which is independent of type I interferons expression(Dixit et al., 2010).  
The authors developed a strategy to distinguish the subcellular positioning of MAVS 
by generating different MAVS alleles that differ in their localization domain, so that they 
can study the isolated organelle-specific actions of MAVS and observe the different 
outcomes in the antiviral response. By deleting the MAVS localization motif, a MAVS-
Cyto allele was created that was found not co-localize with any organelle, remaining in 
the cytosol; by replacing the localization motif of MAVS with the localization motif of 
peroxin Pex13, a MAVS-Pex allele was created and found to localize exclusively in 
peroxisomes. Two other MAVS alleles were generated by targeting two different 
mitochondrial proteins that reside in the mitochondrial outer membrane, OMP25 and 
Fis1. While the MAVS allele harbouring OMP25 was found to localize in both, 
mitochondria and peroxisomes (thus named MAVS-mimic since it mimics wild-type 
MAVS), the Fis1 allele selectively marked mitochondria, thus named MAVS-Mito (Dixit 
et al., 2010). 
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This system allowed the authors to establish that MAVS signaling occurs from both, 
mitochondria and peroxisomes, and that their actions seem to be complementary to 
each other. By examining the expression of a well-known ISG, viperin, in a model of 
reovirus infection, they observed the different outcomes in the antiviral response in 
cells harbouring the individualized MAVS alleles. In MAVS-Pex cells, viperin 
expression was shown to be rapid but, at the same time, transient, since viperin was 
present in early times of the infection, but its levels decrease over time. On the other 
hand, in MAVS-Mito cells, the viperin expression revealed delayed kinetics, with 
increasing and sustained viperin expression levels over time. This could easily indicate 
that, perhaps, the peroxisomal pathway establishes a first outburst of antiviral effector 
proteins to temporarily block the viral replication while the mitochondrial pathway, 
which takes more time to develop, is capable of inducing a stronger and longer lasting 
antiviral state to clear out the infection completely (Dixit et al., 2010).  
These differences in the ISG induction over the course of a viral infection between 
peroxisome- and mitochondria-localized MAVS pathways prompted the authors to 
assume that more than one mechanism of ISG induction was taking place. As 
previously explained in chapter 2, the mitochondrial MAVS signaling pathway is known 
to induce type I IFN production that, in turn, induces ISG expression. So, as expected, 
MAVS-WT, MAVS-Mimic and MAVS-Mito cells triggered IFN production, but curiously, 
MAVS-Pex cells did not produce any detectable levels of IFNs. Thus, some kind of 
IFN-independent mechanism might be responsible to induce ISG production via the 
peroxisomal MAVS pathway (Dixit et al., 2010).  
 
4.2 - Downstream effectors and correlation with IFN-independent ISG 
induction 
Looking for some of the potential downstream regulators of the peroxisomal MAVS 
pathway, Dixit et al. 2010 found TRAF3 and TRAF6 to be involved in this signaling 
pathway and some reporter genes for the functions of NF-kB and AP-1 were induced, 
as well as an IRF1 reporter and an ISRE that typically reports the activity of IRF3. 
Interestingly, the knockout of either IRF1 or IRF3 greatly compromised the ISG 
induction in MAVS-Pex cells, which might indicate a crucial role of these IRFs in the 
IFN-independent ISG induction via the peroxisomal MAVS pathway (Dixit et al., 2010).  
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These findings by seem to correlate with previous studies that attempted to explore 
the IFN-independent ISG induction pathway. Over the last decade it has been revealed 
that ISG production can actually be induced independently from IFN production, 
through the direct actions of IRF3, which is able to bind directly to the ISREs of the 
promoter regions of ISG genes. This happens in very early stages of the infection 
course and it’s thought to be triggered solely by the entry of viral particles into the host 
cell (particularly, when dealing with enveloped viruses). 
Paladino et al. 2006 came up with an hypothesis for the existence of an IFN-
independent pathway to induce ISGs. For most infections, epithelia and fibroblasts are 
the first to contact with the virus, providing the first barrier of antiviral defence. Given 
the likelihood of these cells to be exposed to low levels of viral particles, epithelia and 
fibroblasts are prepared to respond to this stimulus by activating the constitutively 
expressed IRF3. Such response results in an IRF3-dependent, but IFN-independent, 
induction of a small subset of ISGs which are able to efficiently tackle the low viral load 
that entered the host cell. Subsequently, the host cell becomes efficient in controlling 
the infection within itself, without activating a more elaborate immune response. The 
main advantage of this early response is the prevention of the recruitment of immune 
cells and the secretion of pro-inflammatory cytokines that would most definitely cause 
unnecessary cell and tissue damage. Paladino et al. have also previously 
demonstrated the lack of IFNs and pro-inflammatory cytokines and then verified that 
the IFN-independent response is in fact specific for low levels of viral particles. 
However, if this first line of defence fails to control viral infection, the second line of 
defence comes into action with the production and secretion of IFNs, stimulating a 
more powerful and sustained immune response. The IFN production is crucial in this 
second phase, since it allows intercellular communication with the neighbouring cells in 
an attempt to prevent further viral spread (Paladino et al., 2006). 
 
4.3 - Mitochondria and Peroxisomes: orchestrating an optimal antiviral 
response 
Referring back to the Dixit et al. 2010 study, they went on and analysed expression 
profiles in order to check if in fact the mitochondrial and peroxisomal antiviral 
responses are complementary and if they coincide with the general panel of expression 
of the wild-type MAVS cells.  The profiles of MAVS-WT and MAVS-mimic were 
identical, as expected, and the profiles of MAVS-Pex and MAVS-Mito cells revealed a 
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transcriptome that is different from one another but that overlaps with the profile of 
MAVS-WT. This confirms that mitochondria and peroxisomes operate together to 
produce a maximal antiviral response. Furthermore, despite each organelle-specific 
pathway being capable to produce a functional antiviral response on their own, the 
integrated actions of both pathways produce a much greater and robust antiviral 
response –  demonstrated by the fact that the magnitude of gene expression by MAVS-
WT or MAVS-mimic was always greater than the ones in MAVS-Pex or MAVS-Mito 
individually (Dixit et al., 2010).  
 
Figure 26 – Organelle-specific MAVS signalling. 
The RNA helicases RIG-I or MDA5 detect viral RNA and then interact with MAVS on 
mitochondrial membranes. Detection of viral nucleic acids by these helicases and signalling via 
mitochondrial MAVS induces the expression of type I IFNs and eventually leads to virus control. 
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Dixit et al. 2010 show that MAVS is also present on peroxisomes. Peroxisomal MAVS is 
essential for the rapid expression of antiviral genes named ISGs. This gene expression, which 
is independent of type I IFN production, results in an early but transient antiviral response. 
However, type I IFN induction by the mitochondrial MAVS pathway is necessary for the eventual 
clearance of the virus. The different outcomes observed for the two MAVS pathways may relate 
to the fact that peroxisomal MAVS activates IRF1 in addition to IRF3. It is possible that an IRF1-
IRF3 heterodimer induces expression of ISGs but not type I IFNS. Dixit et al. 2010 results reveal 
that MAVS signalling from both, peroxisomes and mitochondria, is necessary for maximal 
containment of virus replication. Text adapted from: (Sharma and Fitzgerald, 2010) 
 
 
4.4 - The peroxisomal branch of the RLR pathway induces the expression of 
type III interferons 
Despite the IFN-independent ISG induction being a plausible hypothesis for the 
peroxisome-dependent antiviral signalling pathway, – since it has been proven that 
several infections are capable of inducing the expression of ISGs independently from 
the induction of type I interferons – the Kagan group recently published a new 
manuscript that presents peroxisomes as a primary site for the initiation of the 
expression of type III interferons (Odendall et al., 2014).   
This follow-up study started by trying to identify if MAVS-Pex cells were able to 
induce the secretion of any kind of extrinsic antiviral factors or if this pathway is entirely 
dependent upon cell-intrinsic factors, by evaluating STAT1 phosphorylation – a known 
downstream effector of the JAK-STAT pathway – which in turn is primarily stimulated 
by interferons. Interestingly, MAVS-Pex cells activated STAT1 phosphorylation, despite 
their inability to induce type I IFN expression. They established the requirement of 
STAT1 and the related JAK kinases (Jak1 and Jak2) in the peroxisome-dependent 
pathway with several inhibitors and small interfering (si)RNA-mediated knockdown 
studies, by determining their influence in the expression of viperin (Odendall et al., 
2014).  
In fact, they discovered that signalling from peroxisomes is dependent upon the 
actions of the JAK-STAT pathway, in order to create an antiviral cellular state. 
However, a key aspect of their findings was the involvement of Jak2 in the peroxisomal 
pathway, a factor that is not involved in type I IFN signalling. Thus, a valid candidate 
that has the properties of the factor secreted from peroxisomal MAVS which induces 
phosphorylation of Jak2 was found to be the recombinant human IFN-λ1, a type III 
interferon (Odendall et al., 2014).  
They found out that an array of viruses such as reovirus, SeV and dengue virus as 
well as the bacterial pathogen Listeria monocytogenes induce the expression of type III 
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interferons via the RLR pathway in human cells. Their research went on to identify 
which MAVS-downstream components of the RLR pathway were responsible for the 
differential activation of the type I and type III interferon pathway, by evaluating the 
effects of IRF3, IRF7, NF-kB and AP-1 (the known requirements for the IFN-β 
enhanceosome). They discovered that IRF3 and NF-kB are required for the activation 
of the IFNL1 gene promoter (Odendall et al., 2014).  
At this point, they focused their attention in a previous finding, the involvement of 
IRF1 in the peroxisomal-dependent antiviral pathway that was brought to light in their 
2010 study. They now establish that, while the knockout of IRF1 has no influence in the 
IFNB1 mRNA levels (thus inferring no influence in the IFN-β expression), it completely 
abolishes the expression of IFNL1 mRNA after SeV infection, thus stating an important 
role of this transcription factor in the control of the expression of type III interferons 
(Odendall et al., 2014).  
 
The results from these recent studies have revealed a fundamental gap in 
knowledge that involves the peroxisomal role in antiviral responses. Thus, future work 
is mandatory to enlighten the intricacies of the implicated signalling pathways that are 
in play.  
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5 – Discussion and Concluding Remarks 
Taking into account the extensive bibliographic review presented in the previous 
chapters, it is very clear the gap in knowledge between the mitochondrial and 
peroxisomal antiviral pathways. It seems that the focus has been made in the search 
for a better understanding of the viral detection mechanisms – probably because PRRs 
are obvious targets for viral therapies or even the development of new vaccines.  
Accordingly, it is still not clear the exact nature of MDA5 ligands, while RIG-I ligands 
properties that allow PRR detection were rapidly unveiled. The only characteristic that 
seems to make sense is the length of the RNA ligands, but that will likely not be the 
only feature that targets viral genomes to MDA5. Are there any other specificities that 
target viral RNAs to MDA5? And why do their ligands bind weaker to MDA5 than the 
ones that bind to RIG-I (in such way that it was even proposed that MDA5 might need 
the help of LGP2 to enhance the affinity of the long viral RNAs to MDA5)?  
Besides the ligand-specificity aspect of MDA5 in the RLR pathway and, in light with 
the results of Dixit et al., 2010, another question arises:  does MDA5, similarly to RIG-I, 
redirect the RLR pathway to peroxisomes? Are the outcomes of the viral infection 
similar to those induced by RIG-I interaction with MAVS? Some of these questions 
could be addressed using the MAVS mutant alleles strategy developed by Dixit et al. 
2010, where MAVS-Mito and MAVS-Pex cells could be used to separately study the 
influence of the MAVS subcellular localization (mitochondria or peroxisomes) in the 
outcome of the antiviral response, MAVS-WT cells would be a viable model to test the 
antiviral outcome as a whole and MAVS-Cyto cells as a negative control.  A possible 
co-localization between MDA5 and mitochondria or peroxisomes could be analysed by 
immunofluorescence microscopy using MDA5- and organelle-specific antibodies.  
To isolate the MDA5-MAVS protein interactions, a co-immunoprecipitation of MDA5 
with mitochondrial MAVS in MAVS-Mito cells or peroxisomal MAVS in MAVS-Pex cells 
could be performed. For the quantification of the MDA5-mediated signalling in the 
antiviral outcome in all types of MAVS alleles cells, ISG expression would have to be 
analysed by an Western blotting procedure, using a target for a specific ISG (i.e.: 
viperin, that’s been shown to be induced in either MAVS-Mito and MAVS-Pex cells 
(Dixit et al., 2010)).  
 
 
 
Universidade de Aveiro                                            Mitochondria and Peroxisomes: role within  
cellular antiviral defense 
 
 
112           Mariana Guedes 
 
The contradicting role of LGP2 did not go unnoticed and has also been extensively 
pursued. It has been clarified that for certain types of viral infections it can exert 
positive regulatory roles (e.g.: encephalomyocarditis, vaccinia,and mengo viruses) 
while for others (e.g.: paramyxovirus Sendai, vesicular stomatitis, Newcastle disease, 
and influenza A viruses), it negatively regulates the RIG-I/MDA5 pathway (Zhu et al., 
2014). Thus, it would be very interesting to study what stimulates LGP2 to exert a 
positive or negative role given a viral infection, or even if there is a particular feature to 
LGP2 or if there are any LGP2-interacting proteins that turns the regulatory role of 
LGP2 into a positive one or into a negative one.   
By revealing that the subcellular localization of MAVS (mitochondria or 
peroxisomes) re-directs the downstream signalling pathways and influence the 
subsequent antiviral responses, Dixit et al. 2010 shed a light into a novel aspect about 
signal transduction pathways: the compartment-specific signalling. Are there key 
elements in signalling pathways that rely on specific organelle localization in order to 
properly exert their functions? Can those pathways be re-directed to other organelles 
(where such key elements would be potentially located) and would they produce 
different responses? Those are some of the challenges worthy of being pursued in a 
near future.  
The involvement of peroxisomes in immune responses might not have come as a 
total surprise, considering the fact that, mitochondria, the housekeeper of the cell and 
the most metabolic diverse organelle, participates in immunity, and shares several 
components and mechanisms with peroxisomes. However, the downstream signalling 
pathway implicating peroxisomes remains poorly studied.  
Therefore, and based on the MAVS interacting partners in the well-established 
mitochondrial pathway, studies regarding the downstream components in the 
peroxisomal pathway are required. Such studies could be carried out in a model of 
MAVS-Pex cells infected with dsRNA viruses that are acknowledged to induce a 
powerful RIG-I activation (as it is the case of the reovirus or Sendai virus). Separate 
expression analysis  would be performed for each and every component that is known 
to act downstream of mitochondrial MAVS (i.e.: TRAF2/6, TRAF3, NF-kB, IRF3, etc.) 
and, as controls for the level of expression of such components, these analyses would 
also have to be performed in infected MAVS-WT cells (positive control) and in non-
infected cells (negative control). Quantification of the expression levels of every single 
component could be evaluated by Western Blot analysis.  
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Another aspect worthy of note regarding these two particular innate immunity 
signalling pathways is the discovery of their potential regulators. Most of the host 
regulators involved in the mitochondrial antiviral pathway were discussed in previous 
chapters and, as expected, the list kept growing over the years. Fluctuating between 
positive or negative regulation actions, a never ending array of molecules, proteins, etc. 
help to put together the complex puzzle of this pathway. Similar studies could be 
performed targeting the peroxisomal branch of the RLR signalling pathway, perhaps 
starting with some of the most well-known regulators of the mitochondrial branch.  
The fact that viruses have developed strategies to evade, subvert and survive within 
the host, manipulating cellular machinery to its own advantage and replication, has 
been thoroughly investigated in several models of infection. For example, it was 
recently found that vMIA (an anti-apoptotic protein encoded by cytomegalovirus) which 
localizes at mitochondria, actually disrupts the MAVS signalling pathway by promoting 
mitochondrial fragmentation (Castanier and Arnoult, 2011; Poncet et al., 2006). Thus, it 
would be interesting to explore whether and how the peroxisomal MAVS signalling is a 
target of vMIA. Potential morphological changes in peroxisomes morphology (such as 
fragmentation and/or elongation) could be determined by immunostaining (in MAVS-
Pex cells with previously transfected vMia) peroxisomes and vMIA through 
immunofluorescence microscopy. 
Another example of a viral protein that directly influences the RLR pathway through 
mitochondrial MAVS is the hepatitis C virus ns3/4a protein, which has been shown to 
directly cleave MAVS, removing it from mitochondria (Li et al., 2005). The challenge 
would be to determine if ns3/4a also cleaves the peroxisomal MAVS and what are the 
effects on the expression of antiviral defence factors such as the ISGs. By 
overexpressing ns3/4a in MAVS-Pex cells and analysing it in different time points 
(through fluorescence microscopy) it could be determined if MAVS “loses” its 
peroxisomal localization and the cleavage could be further confirmed by 
immunoblotting the cleavage products. The implications in the outcome of an infection 
would be determined by quantification of the ISG production. 
The possibilities are endless. Perhaps other organelles possess an immunological 
role, apart from their metabolic functions. As such, the study of host-pathogen 
interactions presents itself as a field with great potential for understanding, not only the 
implicated antiviral signalling pathways, but also the subcellular localization of such 
pathways and to unveil novel therapeutic targets that can be used for the development 
of new and more effective medical treatments. 
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